CAIS
MCID: CMP034
MIFTS: 46

Complete Androgen Insensitivity Syndrome (CAIS)

Categories: Endocrine diseases, Fetal diseases, Rare diseases, Reproductive diseases

Aliases & Classifications for Complete Androgen Insensitivity Syndrome

MalaCards integrated aliases for Complete Androgen Insensitivity Syndrome:

Name: Complete Androgen Insensitivity Syndrome 52 58 29
Cais 52 58
Androgen Insensitivity Syndrome, Complete 52
Androgen Insensitivity Syndrome Complete 54
Complete Androgen Resistance Syndrome 58
Testicular Feminization 71

Characteristics:

Orphanet epidemiological data:

58
complete androgen insensitivity syndrome
Inheritance: X-linked recessive; Age of onset: All ages; Age of death: normal life expectancy;

Classifications:

Orphanet: 58  
Rare infertility disorders
Rare gynaecological and obstetric diseases
Rare endocrine diseases
Developmental anomalies during embryogenesis


External Ids:

ICD10 via Orphanet 33 E34.5
Orphanet 58 ORPHA99429
UMLS 71 C0936016

Summaries for Complete Androgen Insensitivity Syndrome

NIH Rare Diseases : 52 Complete androgen insensitivity syndrome is a condition that affects sexual development before birth and during puberty. People with this condition are genetically male (one X and one Y chromosome ) but do not respond to male hormones at all. As a result, they generally have normal female external genitalia and female breasts. However, they do not have a uterus or cervix so are unable to menstruate or conceive children. Other signs and symptoms may include undescended testes and sparse to absent pubic hair. Gender identity is typically female. Complete androgen insensitivity syndrome is caused by changes (mutations ) in the AR gene and is inherited in an X-linked manner. Treatment and gender assignment can be a very complex issue, and must be individualized with each affected person. In general, surgery may be required to remove testes that are located in unusual places and estrogen replacement therapy can be prescribed after puberty.

MalaCards based summary : Complete Androgen Insensitivity Syndrome, also known as cais, is related to seminoma and androgen insensitivity syndrome. An important gene associated with Complete Androgen Insensitivity Syndrome is AR (Androgen Receptor), and among its related pathways/superpathways are Metabolism of proteins and Glucose / Energy Metabolism. The drugs Anesthetics and Fibrin Tissue Adhesive have been mentioned in the context of this disorder. Affiliated tissues include uterus, testes and breast, and related phenotypes are cryptorchidism and primary amenorrhea

Wikipedia : 74 Complete androgen insensitivity syndrome (CAIS) is a condition that results in the complete inability of... more...

Related Diseases for Complete Androgen Insensitivity Syndrome

Diseases related to Complete Androgen Insensitivity Syndrome via text searches within MalaCards or GeneCards Suite gene sharing:

(showing 174, show less)
# Related Disease Score Top Affiliating Genes
1 seminoma 30.6 IGF2 CGA ALPG
2 androgen insensitivity syndrome 30.6 SRY SHBG PTGDS NR1H2 MUC5AC MUC1
3 testicular cancer 30.2 SHBG CGA AR
4 gender identity disorder 30.1 CYP19A1 AR
5 sertoli cell tumor 29.9 MUC1 CYP19A1 AR
6 hyperinsulinism 29.9 SHBG IGFBP3 IGF2
7 androgen insensitivity, partial 29.8 SHBG LYVE1 CYP19A1 AR
8 disorders of sexual development 29.7 SHBG IGFBP3 CYP19A1 AR
9 infertility 29.7 SHBG CYP19A1 CGA AR
10 pseudohermaphroditism 29.7 SRY CYP19A1 AR
11 germ cell cancer 29.6 IGFBP2 IGF2 CGA AR ALPG
12 alopecia, androgenetic, 1 29.5 SHBG CYP19A1 AR
13 46,xy sex reversal 29.5 SRY CYP19A1 AR
14 male infertility 29.2 SRY SHBG CYP19A1 AR
15 turner syndrome 28.9 SRY SHBG IGFBP3 IGF2 AR
16 androgenic alopecia 28.9 SHBG PTGDS CYP19A1 AR
17 gynecomastia 28.5 SRY SHBG CYP19A1 CGA AR
18 polycystic ovary syndrome 28.4 SHBG IGFBP3 IGF2 CYP19A1 CGA AR
19 vitreoretinochoroidopathy 11.4
20 amenorrhea 10.8
21 inguinal hernia 10.6
22 adenoma 10.4
23 gonadal dysgenesis 10.4
24 bladder cancer 10.3
25 multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia, and hydranencephaly 10.3
26 leydig cell tumor 10.3
27 sertoli-leydig cell tumor 10.3
28 reticulum cell sarcoma 10.3 MUC1 LYVE1
29 apocrine adenocarcinoma 10.3 MUC1 AR
30 glioblastoma multiforme 10.2
31 testicular germ cell tumor 10.2
32 testicular germ cell cancer 10.2
33 in situ carcinoma 10.2
34 germ cells tumors 10.2
35 fetal macrosomia 10.2 IGFBP3 IGF2
36 intrahepatic biliary papillomatosis 10.2 MUC5AC MUC1
37 biliary papillomatosis 10.2 MUC5AC MUC1
38 colloid carcinoma of the pancreas 10.2 MUC5AC MUC1
39 acid-labile subunit deficiency 10.2 IGFBP3 IGF2
40 urinary bladder villous adenoma 10.2 MUC5AC MUC1
41 bile duct mucinous adenocarcinoma 10.2 MUC5AC MUC1
42 mucinous intrahepatic cholangiocarcinoma 10.2 MUC5AC MUC1
43 bile duct cystadenocarcinoma 10.2 MUC5AC MUC1
44 pseudovaginal perineoscrotal hypospadias 10.2 IGFBP3 CGA AR
45 bile duct mucoepidermoid carcinoma 10.2 MUC5AC MUC1
46 chronic ethmoiditis 10.2 MUC5AC MUC1
47 hyperpituitarism 10.2 IGFBP3 IGF2
48 biliary tract benign neoplasm 10.1 MUC5AC MUC1
49 pancreatic mucinous cystadenoma 10.1 MUC5AC MUC1
50 rhabdoid tumor predisposition syndrome 1 10.1 MUC1 IGF2
51 anorchia 10.1 SRY CGA
52 filamentary keratitis 10.1 MUC5AC MUC1
53 prostatic hyperplasia, benign 10.1 SHBG AR
54 tumor of exocrine pancreas 10.1 MUC5AC MUC1
55 hepatocellular carcinoma 10.1
56 constipation 10.1
57 kidney cancer 10.1
58 lipoid congenital adrenal hyperplasia 10.1
59 hypospadias 10.1
60 leiomyoma 10.1
61 syndrome with 46,xy disorder of sex development 10.1
62 solid adenocarcinoma with mucin production 10.1 MUC5AC MUC1
63 limbal stem cell deficiency 10.1 MUC5AC MUC1
64 colorectal cancer, hereditary nonpolyposis, type 8 10.1 MUC5AC MUC1
65 appendix disease 10.1 MUC5AC MUC1
66 gastric diffuse adenocarcinoma 10.1 MUC5AC MUC1
67 47,xyy 10.1 SRY IGFBP3
68 appendix cancer 10.1 MUC5AC MUC1
69 marasmus 10.1 SHBG IGFBP3
70 laron syndrome 10.1 IGFBP3 IGFBP2 IGF2
71 meconium ileus 10.1 MUC5AC MUC1
72 varicocele 10.0 SHBG CGA AR
73 paget disease, extramammary 10.0 MUC5AC MUC1 AR
74 atrial standstill 1 10.0
75 autoimmune disease 10.0
76 leukemia, chronic lymphocytic 10.0
77 rheumatoid arthritis 10.0
78 small cell cancer of the lung 10.0
79 spondylolisthesis 10.0
80 lung cancer 10.0
81 ataxia and polyneuropathy, adult-onset 10.0
82 premature ovarian failure 7 10.0
83 gastric cancer 10.0
84 chronic atrial and intestinal dysrhythmia 10.0
85 withdrawal disorder 10.0
86 pain agnosia 10.0
87 scoliosis 10.0
88 thalassemia 10.0
89 rabies 10.0
90 allergic hypersensitivity disease 10.0
91 chagas disease 10.0
92 neutropenia 10.0
93 retinal ischemia 10.0
94 bacteriuria 10.0
95 disease of mental health 10.0
96 cerebral palsy 10.0
97 transitional cell carcinoma 10.0
98 fibrosarcoma 10.0
99 plague 10.0
100 liver disease 10.0
101 poliomyelitis 10.0
102 stomach disease 10.0
103 back pain 10.0
104 meckel diverticulum 10.0
105 testicular torsion 10.0
106 down syndrome 10.0
107 renal hypodysplasia/aplasia 1 10.0
108 congenital heart defects, hamartomas of tongue, and polysyndactyly 10.0
109 mayer-rokitansky-kuster-hauser syndrome 10.0
110 46,xy sex reversal 1 10.0
111 bone mineral density quantitative trait locus 3 10.0
112 anxiety 10.0
113 sexual disorder 10.0
114 infant gynecomastia 10.0
115 telangiectasis 10.0
116 mixed gonadal dysgenesis 10.0
117 breast fibroadenoma 10.0
118 lipid metabolism disorder 10.0
119 clear cell adenofibroma 10.0
120 cystadenofibroma 10.0
121 appendicitis 10.0
122 alopecia 10.0
123 46, xy disorders of sexual development 10.0
124 chromosomal triplication 10.0
125 precocious puberty 10.0
126 central precocious puberty 10.0
127 tetragametic chimerism 10.0
128 microtia 10.0
129 transsexualism 10.0 CYP19A1 AR
130 oocyte maturation defect 1 10.0 CYP19A1 CGA
131 duodenum cancer 10.0 MUC5AC MUC1
132 thyroid hormone resistance, generalized, autosomal dominant 10.0 SHBG NR1H2
133 duodenum disease 10.0 MUC5AC MUC1
134 vaginal adenoma 9.9 IGF2 CYP19A1
135 colorectal cancer 1 9.9 MUC5AC MUC1
136 nephroma 9.9 MUC1 IGF2
137 vaginal benign neoplasm 9.9 IGF2 CYP19A1
138 hemangioma 9.9 MUC1 LYVE1 IGF2
139 mammographic density 9.9 IGFBP3 CYP19A1
140 papilloma of choroid plexus 9.9 MUC1 IGF2
141 dysgerminoma 9.9 SRY MUC1 ALPG
142 premature ejaculation 9.8 CYP19A1 AR
143 prader-willi syndrome 9.8 IGFBP3 IGFBP2 IGF2 AR
144 postmenopausal atrophic vaginitis 9.8 SHBG CYP19A1
145 anorexia nervosa 9.8 SHBG IGFBP3 IGFBP2
146 pre-eclampsia 9.8 IGFBP3 IGF2 CGA AR
147 hypoactive sexual desire disorder 9.8 SHBG CYP19A1
148 ovarian cyst 9.7 IGFBP2 CYP19A1 CGA
149 estrogen excess 9.7 SHBG CYP19A1
150 ductal carcinoma in situ 9.7 MUC1 CYP19A1 AR
151 insulin-like growth factor i 9.7 SHBG IGFBP3 IGFBP2 IGF2
152 acromegaly 9.7 SHBG IGFBP3 IGFBP2 IGF2
153 aromatase excess syndrome 9.7 SHBG CYP19A1
154 prostatic hypertrophy 9.7 SHBG CYP19A1 AR
155 luteoma 9.6 SHBG CYP19A1 CGA
156 ovarian hyperstimulation syndrome 9.6 SHBG CYP19A1 CGA
157 hermaphroditism 9.6 SRY SHBG CGA AR
158 asperger syndrome 9.6 IGF2 CYP19A1 CGA AR
159 leiomyoma, uterine 9.6 SHBG IGF2 CYP19A1
160 choriocarcinoma 9.6 IGF2 CYP19A1 CGA ALPG
161 steroid inherited metabolic disorder 9.5 SHBG CYP19A1
162 breast ductal carcinoma 9.4 MUC5AC MUC1 CYP19A1 AR
163 premature ovarian failure 1 9.4 SHBG IGFBP3 CYP19A1 AR
164 anovulation 9.3 SHBG IGFBP3 CYP19A1 CGA
165 lobular neoplasia 9.3 MUC1 CYP19A1
166 breast disease 9.3 SHBG IGFBP3 IGF2 CYP19A1
167 cryptorchidism, unilateral or bilateral 9.2 SHBG CYP19A1 CGA AR ALPG
168 ovarian disease 9.2 SHBG IGFBP2 CYP19A1 CGA AR
169 hyperandrogenism 9.1 SHBG IGFBP3 IGF2 CYP19A1 AR
170 osteoporosis 8.9 SHBG IGFBP3 IGFBP2 IGF2 CYP19A1 AR
171 endometrial cancer 8.8 SHBG MUC1 IGFBP3 IGF2 CYP19A1 AR
172 body mass index quantitative trait locus 11 8.7 SHBG NR1H2 IGFBP3 IGFBP2 IGF2 CYP19A1
173 ovarian cancer 8.3 MUC5AC MUC1 LYVE1 IGFBP3 IGFBP2 IGF2
174 prostate cancer 8.1 SHBG NR1H2 MUC1 LYVE1 IGFBP3 IGFBP2

Graphical network of the top 20 diseases related to Complete Androgen Insensitivity Syndrome:



Diseases related to Complete Androgen Insensitivity Syndrome

Symptoms & Phenotypes for Complete Androgen Insensitivity Syndrome

Human phenotypes related to Complete Androgen Insensitivity Syndrome:

58 31 (showing 16, show less)
# Description HPO Frequency Orphanet Frequency HPO Source Accession
1 cryptorchidism 58 31 hallmark (90%) Very frequent (99-80%) HP:0000028
2 primary amenorrhea 58 31 hallmark (90%) Very frequent (99-80%) HP:0000786
3 nephrolithiasis 58 31 hallmark (90%) Very frequent (99-80%) HP:0000787
4 male pseudohermaphroditism 58 31 hallmark (90%) Very frequent (99-80%) HP:0000037
5 infertility 58 31 hallmark (90%) Very frequent (99-80%) HP:0000789
6 aplasia of the uterus 58 31 hallmark (90%) Very frequent (99-80%) HP:0000151
7 absent axillary hair 58 31 hallmark (90%) Very frequent (99-80%) HP:0002221
8 absent pubic hair 58 31 hallmark (90%) Very frequent (99-80%) HP:0002555
9 aplasia/hypoplasia of the fallopian tube 58 31 hallmark (90%) Very frequent (99-80%) HP:0008655
10 inguinal hernia 58 31 frequent (33%) Frequent (79-30%) HP:0000023
11 osteoporosis 58 31 frequent (33%) Frequent (79-30%) HP:0000939
12 sensory neuropathy 58 31 occasional (7.5%) Occasional (29-5%) HP:0000763
13 tremor 58 31 occasional (7.5%) Occasional (29-5%) HP:0001337
14 gynecomastia 58 31 occasional (7.5%) Occasional (29-5%) HP:0000771
15 muscle spasm 58 31 occasional (7.5%) Occasional (29-5%) HP:0003394
16 testicular gonadoblastoma 58 31 occasional (7.5%) Occasional (29-5%) HP:0000030

MGI Mouse Phenotypes related to Complete Androgen Insensitivity Syndrome:

45 (showing 1, show less)
# Description MGI Source Accession Score Top Affiliating Genes
1 liver/biliary system MP:0005370 9.1 AR CYP19A1 IGF2 IGFBP2 IGFBP3 NR1H2

Drugs & Therapeutics for Complete Androgen Insensitivity Syndrome

Drugs for Complete Androgen Insensitivity Syndrome (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(showing 6, show less)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1 Anesthetics Phase 4
2 Fibrin Tissue Adhesive Phase 3
3
Ethanol Approved Phase 2 64-17-5 702
4 Anticonvulsants Phase 2
5 Anti-Infective Agents, Local Phase 1
6 Anti-Infective Agents Phase 1

Interventional clinical trials:

(showing 8, show less)
# Name Status NCT ID Phase Drugs
1 One-abutment One-time for Immediate Restoration Procedure in the Esthetic Zone: A Randomized Controlled Trial Comparing Conventional Versus Full Digital Workflow Completed NCT04139512 Phase 4
2 A Randomised Clinical Trial Comparing a Novel Single-stage Autologous Cartilage Implantation System to Conventional Microfracture for Repair of Articular Cartilage Defects in the Knee Unknown status NCT01498029 Phase 3
3 Rapid Determination Of The Clinical Utility Of Perampanel For The Treatment Of Alcohol Dependence Active, not recruiting NCT02120365 Phase 2 Perampanel;Placebo
4 Nicotinic Receptor Genetic Variation and Alcohol Reward Recruiting NCT03294460 Phase 1 Alcohol (Oral);Alcohol (IV);Alcohol (Ethanol)
5 Project 4: Acute Effects of Alcohol on Learning and Habitization in Healthy Young Adults Completed NCT01858818
6 VoiceS: Voice Quality After Transoral CO2-Laser Surgery Versus Single Vocal Cord Irradiation for Unilateral Stage 0 & I Glottic Larynx Cancer - A Randomized Phase III Trial Recruiting NCT04057209
7 Retrospective Observational Study Determining the Clinical Effectiveness of Whole Genome and Transcriptome Analysis to Guide Advanced Cancer Care Active, not recruiting NCT04141397
8 A Multicenter, Randomized, Pivotal Study to Evaluate the Safety and Efficacy of the Cartilage Autograft Implantation System (CAIS) for the Surgical Treatment of Articular Cartilage Lesions of the Knee Terminated NCT00881023

Search NIH Clinical Center for Complete Androgen Insensitivity Syndrome

Genetic Tests for Complete Androgen Insensitivity Syndrome

Genetic tests related to Complete Androgen Insensitivity Syndrome:

# Genetic test Affiliating Genes
1 Complete Androgen Insensitivity Syndrome 29

Anatomical Context for Complete Androgen Insensitivity Syndrome

MalaCards organs/tissues related to Complete Androgen Insensitivity Syndrome:

40
Uterus, Testes, Breast, Cervix, Bone, Skin, Brain

Publications for Complete Androgen Insensitivity Syndrome

Articles related to Complete Androgen Insensitivity Syndrome:

(showing 859, show less)
# Title Authors PMID Year
1
Two de novo mutations in the AR gene cause the complete androgen insensitivity syndrome in a pair of monozygotic twins. 54 61 6
11889162 2002
2
A novel mutation in the CAG triplet region of exon 1 of androgen receptor gene causes complete androgen insensitivity syndrome in a large kindred. 54 61 6
10323385 1999
3
Mosaicism due to a somatic mutation of the androgen receptor gene determines phenotype in androgen insensitivity syndrome. 6 54 61
9360511 1997
4
Extreme androgen resistance in a kindred with a novel insertion/deletion mutation in exon 5 of the androgen receptor gene. 61 6
12908100 2003
5
Complete androgen insensitivity syndrome caused by a novel mutation in the ligand-binding domain of the androgen receptor: functional characterization. 6 61
12213902 2002
6
Genotype versus phenotype in families with androgen insensitivity syndrome. 61 6
11549642 2001
7
Androgen Insensitivity Syndrome 6 61
20301602 1999
8
A novel substitution (Leu707Arg) in exon 4 of the androgen receptor gene causes complete androgen resistance. 6 54
8626869 1996
9
Leu-676-Pro mutation of the androgen receptor causes complete androgen insensitivity syndrome in a large Hutterite kindred. 61 6
7537149 1995
10
Complete androgen insensitivity syndrome associated with a de novo mutation of the androgen receptor gene detected by single strand conformation polymorphism. 61 6
8096390 1993
11
Androgen receptor gene mutations identified by SSCP in fourteen subjects with androgen insensitivity syndrome. 6 61
1307250 1992
12
A single amino acid substitution (Met786----Val) in the steroid-binding domain of human androgen receptor leads to complete androgen insensitivity syndrome. 61 6
1569163 1992
13
Sequence of the intron/exon junctions of the coding region of the human androgen receptor gene and identification of a point mutation in a family with complete androgen insensitivity. 6 61
2594783 1989
14
Deletion of the steroid-binding domain of the human androgen receptor gene in one family with complete androgen insensitivity syndrome: evidence for further genetic heterogeneity in this syndrome. 61 6
3186717 1988
15
Pathophysiology of androgen insensitivity syndromes: molecular and structural approaches of natural and engineered androgen receptor mutations at amino acid 743. 6
12466388 2002
16
Male fertility is compatible with an Arg(840)Cys substitution in the AR in a large Chinese family affected with divergent phenotypes of AR insensitivity syndrome. 6
11788673 2002
17
A G577R mutation in the human AR P box results in selective decreases in DNA binding and in partial androgen insensitivity syndrome. 6
11579211 2001
18
A unique exonic splicing mutation in the human androgen receptor gene indicates a physiologic relevance of regular androgen receptor transcript variants. 6
11397856 2001
19
Significance of the CAG repeat length in the androgen receptor gene (AR) for the transactivation function of an M780I mutant AR. 6
10323251 1999
20
Mutations of the androgen receptor gene in patients with complete androgen insensitivity. 6
8990010 1997
21
Androgen insensitivity syndrome due to new mutations in the DNA-binding domain of the androgen receptor. 6
8809734 1996
22
A single amino acid substitution (gly743 --> val) in the steroid-binding domain of the human androgen receptor leads to Reifenstein syndrome. 6
8325932 1993
23
Complete testicular feminization caused by an amino-terminal truncation of the androgen receptor with downstream initiation. 6
8450040 1993
24
Related individuals with different androgen receptor gene deletions. 6
8450042 1993
25
Replacement of arginine 773 by cysteine or histidine in the human androgen receptor causes complete androgen insensitivity with different receptor phenotypes. 6
1609793 1992
26
Amber mutation creates a diagnostic MaeI site in the androgen receptor gene of a family with complete androgen insensitivity. 6
1720929 1991
27
Definition of the human androgen receptor gene structure permits the identification of mutations that cause androgen resistance: premature termination of the receptor protein at amino acid residue 588 causes complete androgen resistance. 6
2293020 1990
28
An exonic point mutation of the androgen receptor gene in a family with complete androgen insensitivity. 6
2339702 1990
29
A single nucleotide substitution introduces a premature termination codon into the androgen receptor gene of a patient with receptor-negative androgen resistance. 6
2332504 1990
30
The human androgen receptor: complementary deoxyribonucleic acid cloning, sequence analysis and gene expression in prostate. 6
3216866 1988
31
Multiplicity of genetic polymorphisms of blood in the Schmiedeleut Hutterites. 6
4061484 1985
32
Novel (60%) and recurrent (40%) androgen receptor gene mutations in a series of 59 patients with a 46,XY disorder of sex development. 54 61
20150575 2010
33
A double nucleotide insertion-induced frame-shift mutation of the androgen receptor gene in a familial complete androgen insensitivity syndrome. 54 61
19815331 2010
34
[Mutation analysis of the androgen receptor gene in a complete androgen insensitivity syndrome family]. 54 61
19953479 2009
35
A case of complete androgen insensitivity syndrome presenting with incarcerated inguinal hernia: an immunohistochemical study. 54 61
19539906 2009
36
Identification of a critical novel mutation in the exon 1 of androgen receptor gene in 2 brothers with complete androgen insensitivity syndrome. 61 54
19023143 2009
37
Androgen receptor roles in spermatogenesis and fertility: lessons from testicular cell-specific androgen receptor knockout mice. 54 61
19176467 2009
38
In-vitro characterization of androgen receptor mutations associated with complete androgen insensitivity syndrome reveals distinct functional deficits. 61 54
18577874 2008
39
Intrinsic androgen-dependent gene expression patterns revealed by comparison of genital fibroblasts from normal males and individuals with complete and partial androgen insensitivity syndrome. 54 61
17945006 2007
40
Primary amenorrhea in a young Polish woman with complete androgen insensitivity syndrome and Sertoli-Leydig cell tumor: identification of a new androgen receptor gene mutation and evidence of aromatase hyperactivity and apoptosis dysregulation within the tumor. 54 61
17852420 2007
41
L859F mutation in androgen receptor gene results in complete loss of androgen binding to the receptor. 54 61
17522416 2007
42
A novel androgen receptor mutation resulting in complete androgen insensitivity syndrome and bilateral Leydig cell hyperplasia. 54 61
16582414 2006
43
Testicular development in the complete androgen insensitivity syndrome. 61 54
16400621 2006
44
Complete androgen insensitivity syndrome caused by the R855H mutation in the androgen receptor gene. 61 54
15813610 2005
45
Transactivation properties of wild-type and mutant androgen receptors in transiently transfected primary human fibroblasts. 61 54
15812177 2005
46
An examination of how different mutations at arginine 855 of the androgen receptor result in different androgen insensitivity phenotypes. 54 61
15118070 2004
47
Novel androgen receptor gene mutations in Australian patients with complete androgen insensitivity syndrome. 54 61
14974091 2004
48
Bridging structural biology and genetics by computational methods: an investigation into how the R774C mutation in the AR gene can result in complete androgen insensitivity syndrome. 61 54
14635106 2003
49
Novel point mutations in complete androgen insensitivity syndrome with incomplete müllerian regression: two Taiwanese patients. 54 61
13680382 2003
50
Androgen receptor gene and male infertility. 61 54
12638777 2003
51
Androgen receptor gene mutation identified by PCR-SSCP and sequencing in 4 patients with complete androgen insensitivity syndrome. 61 54
10834333 2000
52
Molecular basis of androgen receptor diseases. 61 54
10711573 2000
53
A novel E153X point mutation in the androgen receptor gene in a patient with complete androgen insensitivity syndrome. 54 61
11225909 1999
54
Screening for mutations in candidate genes for hypospadias. 54 61
10092153 1999
55
One additional mutation at exon A amplifies thermolability of androgen receptor in a case with complete androgen insensitivity syndrome. 61 54
9610419 1998
56
A(870)E mutation of the androgen receptor gene in a patient with complete androgen insensitivity syndrome and Sertoli cell tumor. 61 54
9332480 1997
57
A novel splice site mutation in the androgen receptor gene results in exon skipping and a non-functional truncated protein. 61 54
9296379 1997
58
Localisation of androgen receptors in dermal fibroblasts, grown in vitro, from normal subjects and from patients with androgen insensitivity syndrome. 54 61
7590636 1995
59
Point mutation in the steroid-binding domain of the androgen receptor gene in a family with complete androgen insensitivity syndrome (CAIS). 54 61
1487249 1992
60
Isoelectric focusing and 2D electrophoresis of the human androgen receptor. 61 54
1734935 1992
61
Phosphonamidates are the first phosphorus-based zinc binding motif to show inhibition of β-class carbonic anhydrases from bacteria, fungi, and protozoa. 61
31663383 2020
62
Screening of benzenesulfonamide in combination with chemically diverse fragments against carbonic anhydrase by differential scanning fluorimetry. 61
31797704 2020
63
Development of a cheminformatics platform for selectivity analyses of carbonic anhydrase inhibitors. 61
31854205 2020
64
Exploring structure-activity relationship of S-substituted 2-mercaptoquinazolin-4(3H)-one including 4-ethylbenzenesulfonamides as human carbonic anhydrase inhibitors. 61
32009479 2020
65
Bioorganometallic derivatives of 4-hydrazino-benzenesulphonamide as carbonic anhydrase inhibitors: synthesis, characterisation and biological evaluation. 61
32037900 2020
66
N-aryl-N'-ureido-O-sulfamates as potent and selective inhibitors of hCA VB over hCA VA: Deciphering the binding mode of new potential agents in mitochondrial dysfunctions. 61
32413627 2020
67
Exploring the multiple binding modes of inhibitors to carbonic anhydrases for novel drug discovery. 61
32208982 2020
68
Community- and Hospital-Acquired Infections in Surgical patients at a Tertiary Referral Hospital in Rwanda. 61
32535645 2020
69
Sulfonamide Inhibitors of Human Carbonic Anhydrases Designed through a Three-Tails Approach: Improving Ligand/Isoform Matching and Selectivity of Action. 61
32519851 2020
70
Genetic and codon usage bias analyses of major capsid protein gene in Ranavirus. 61
32497680 2020
71
Antimicrobial resistance in southern China: results of prospective surveillance in Dongguan city, 2017. 61
32243952 2020
72
Prevalence and characteristics of surgical site hypervirulent Klebsiella pneumoniae isolates. 61
32424981 2020
73
Tail approach synthesis of novel benzenesulfonamides incorporating 1,3,4-oxadiazole hybrids as potent inhibitor of carbonic anhydrase I, II, IX, and XII isoenzymes. 61
32203788 2020
74
Hypoxia-Activated Prodrug Derivatives of Carbonic Anhydrase Inhibitors in Benzenesulfonamide Series: Synthesis and Biological Evaluation. 61
32443462 2020
75
Pediatric blunt cerebrovascular injuries: A national trauma database study. 61
32089272 2020
76
Disorders of sexual development with XY karyotype and female phenotype: clinical findings and genetic background in a cohort from a single centre. 61
32378143 2020
77
The Carbonic Anhydrase Inhibitor Dorzolamide Stimulates the Differentiation of Human Meibomian Gland Epithelial Cells. 61
32434386 2020
78
Efficacy and safety of adsorptive granulomonocytapheresis in Chinese patients with ulcerative colitis: A retrospective analysis of 50 cases with focus on factors impacting clinical efficacy. 61
32378240 2020
79
Generation of human induced pluripotent stem cell (SKLRMi001-A) from a patient with partial androgen insensitivity syndrome (PAIS). 61
32505105 2020
80
17β-hydroxysteroid dehydrogenase type 3 deficiency: female sex assignment and follow-up. 61
32297288 2020
81
A young girl with right ovarian torsion and left ovarian ectopy. 61
32326964 2020
82
Clinical, hormonal and genetic characteristics of androgen insensitivity syndrome in 39 Chinese patients. 61
32345305 2020
83
Patient-Reported Outcome Measures (PROMs) for Two Implant Placement Techniques in Sinus Region (Bone Graft versus Computer-Aided Implant Surgery): A Randomized Prospective Trial. 61
32344891 2020
84
An update on drug interaction considerations in the therapeutic use of carbonic anhydrase inhibitors. 61
32172611 2020
85
Benzylaminoethyureido-Tailed Benzenesulfonamides: Design, Synthesis, Kinetic and X-ray Investigations on Human Carbonic Anhydrases. 61
32272689 2020
86
Inclusion of a 5-fluorouracil moiety in nitrogenous bases derivatives as human carbonic anhydrase IX and XII inhibitors produced a targeted action against MDA-MB-231 and T47D breast cancer cells. 61
32044580 2020
87
Primordial formation of major silicates in a protoplanetary disc with homogeneous 26Al/27Al. 61
32195348 2020
88
Accuracy of implant position when placed using static computer-assisted implant surgical guides manufactured with two different optical scanning techniques: a randomized clinical trial. 61
31543382 2020
89
Randomized Trial of a Computer-Assisted Intervention for Children With Autism in Schools. 61
30953731 2020
90
Short-term outcomes of subtenon triamcinolone acetonide injections in patients with retinitis pigmentosa-associated cystoid macular edema unresponsive to carbonic anhydrase inhibitors. 61
31773389 2020
91
Mental health outcomes among individuals with 46,XY disorders of sex development: A systematic review. 61
32133887 2020
92
Conservative Management of Vaginal Hypoplasia 61
32041393 2020
93
Role of platelet gene polymorphisms in ischemic pediatric stroke subtypes: a case-control study. 61
32118374 2020
94
Application and Perceived Effectiveness of Complementary and Alternative Intervention Strategies for Attention-Deficit/Hyperactivity Disorder: Relationships with Affiliate Stigma. 61
32110955 2020
95
Androgen Insensitivity Syndrome: A rare genetic disorder. 61
32493623 2020
96
Magnesium isotopes of the bulk solar wind from Genesis diamond-like carbon films. 61
32214784 2020
97
Q-gases in a late-forming refractory interplanetary dust particle: A link to comet Wild 2. 61
32214433 2020
98
Particulated Cartilage for Chondral and Osteochondral Repair: A Review. 61
32052642 2020
99
Sulfonamide/sulfamate switch with a series of piperazinylureido derivatives: Synthesis, kinetic and in silico evaluation as carbonic anhydrase isoforms I, II, IV, and IX inhibitors. 61
31784185 2020
100
Experiences and effectiveness of canine-assisted interventions on the health and well-being of older people residing in long-term care: a mixed methods systematic review protocol. 61
31904723 2020
101
Evidence of presolar SiC in the Allende Curious Marie calcium aluminum rich inclusion. 61
32021908 2020
102
CAD-CAM cobalt-chromium surgical template for static computer-aided implant surgery: A dental technique. 61
31153612 2020
103
Induced Lactation in a Mother Through Surrogacy With Complete Androgen Insensitivity Syndrome (CAIS). 61
31895601 2020
104
Suspected Spontaneous Aqueous Humor Misdirection Syndrome in a Boston Terrier. 61
32550038 2020
105
Direct and straightforward access to substituted alkyl selenols as novel carbonic anhydrase inhibitors. 61
31693947 2020
106
The risk of mental disorders in patients with disorders/differences of sex differentiation/development (DSD) and Y chromosome. 61
32129466 2020
107
One-step hydrophobization of tannic acid for antibacterial coating on catheters to prevent catheter-associated infections. 61
31535105 2019
108
Late diagnosis of complete androgen insensitivity syndrome and transmission/carriers of the condition in a family with mutation c.2495G> T p.(Arg832Leu) in exon 7 of the androgen receptor gene: genetic, clinical and ethical aspects. 61
30401990 2019
109
Identification of two additional novel mutations in the AR gene associated with severe forms of androgen insensitivity syndrome. 61
31499074 2019
110
Bone mineral density, body composition and metabolic profiles in adult women with complete androgen insensitivity syndrome and removed gonads using oral or transdermal estrogens. 61
31491747 2019
111
[Androgen insensitivity syndrome discovered due to discordance in prenatal assessments of fetal gender]. 61
31928615 2019
112
Novel 2-substituted-benzimidazole-6-sulfonamides as carbonic anhydrase inhibitors: synthesis, biological evaluation against isoforms I, II, IX and XII and molecular docking studies. 61
31537132 2019
113
Origin of 16O-rich fine-grained Ca-Al-rich inclusions of different mineralogy and texture. 61
32020946 2019
114
Phaeodactylum tricornutum as a model organism for testing the membrane penetrability of sulphonamide carbonic anhydrase inhibitors. 61
30688123 2019
115
Spirocyclic sulfonamides with carbonic anhydrase inhibitory and anti-neuropathic pain activity. 61
31473472 2019
116
Carbonic anhydrase inhibitors based on sorafenib scaffold: Design, synthesis, crystallographic investigation and effects on primary breast cancer cells. 61
31419777 2019
117
Advances in the structural annotation of human carbonic anhydrases and impact on future drug discovery. 61
31436118 2019
118
The XY Female: Exploring Care for Adolescent Girls with Complete Androgen Insensitivity Syndrome. 61
31751516 2019
119
A shared decision-making tool for individuals living with complete androgen insensitivity syndrome. 61
31668289 2019
120
Novel Mutations Segregating with Complete Androgen Insensitivity Syndrome and their Molecular Characteristics. 61
31671693 2019
121
Complete Androgen Insensitivity Syndrome: Dilemmas for Further Management after Gonadectomy. 61
32038088 2019
122
Somatic mosaicism of androgen receptor gene in an androgen insensitivity syndrome patient conceived through assisted reproduction technique. 61
31429517 2019
123
Features of the fetal gonad in androgen synthesis in the postpubertal testis are preserved in complete androgen insensitivity syndrome due to a novel genetic splice site donor variant in androgen receptor gene intron 1. 61
31283987 2019
124
Carbonic anhydrase inhibition and the management of glaucoma: a literature and patent review 2013-2019. 61
31596641 2019
125
Mycobacterium tuberculosisβ-Carbonic Anhydrases: Novel Targets for Developing Antituberculosis Drugs. 61
31627429 2019
126
Real-time tracking of surgical instruments based on spatio-temporal context and deep learning. 61
30760050 2019
127
CX3CR1-CCR2-dependent monocyte-microglial signaling modulates neurovascular leakage and acute injury in a mouse model of childhood stroke. 61
30628839 2019
128
The accuracy of single-tooth implants placed using fully digital-guided surgery and freehand implant surgery. 61
31241782 2019
129
Aluminum-26 chronology of dust coagulation and early solar system evolution. 61
31535020 2019
130
Evidencing the impact of coaches' learning: Changes in coaching knowledge and practice over time. 61
31135293 2019
131
Extended chondrule formation intervals in distinct physicochemical environments: Evidence from Al-Mg isotope systematics of CR chondrite chondrules with unaltered plagioclase. 61
32255837 2019
132
Long-term consequences of androgen insensitivity syndrome. 61
31351520 2019
133
Disorders of Sex Development: A 10 Years Experience with 73 Cases from the Kashmir Valley. 61
31803600 2019
134
Laparoscopic Bilateral Gonadectomy and Inguinal Hernia Repair with Mesh for Complete Androgen Insensitivity Syndrome: A Case Report. 61
30825542 2019
135
Postnatal germ cell development during first 18 months of life in testes from boys with non-syndromic cryptorchidism and complete or partial androgen insensitivity syndrome. 61
30739749 2019
136
N-aryl-N'-ureido-O-sulfamates: Potent and selective inhibitors of the human Carbonic Anhydrase VII isoform with neuropathic pain relieving properties. 61
31212085 2019
137
A Survey of School Nurses' Perceptions of Complementary, Alternative, and Integrative Therapies. 61
29681230 2019
138
Association of Depression and Excessive Daytime Sleepiness among Sleep-Deprived College Freshmen in Northern Taiwan. 61
31470500 2019
139
Epidemiology of Bloodstream Infections in Hospitalized Children in the United States, 2009-2016. 61
30534940 2019
140
Specific Biomarkers of Prostate Cancer-Associated Ischemic Stroke: A Case-Control Study. 61
31383837 2019
141
A novel missense mutation in the androgen receptor gene causes the complete androgen insensitivity syndrome. 61
30964356 2019
142
Diagnosis of female 17α-hydroxylase deficiency after gonadectomy: a case report. 61
31358067 2019
143
Carbonic anhydrase inhibitors in patients with X-linked retinoschisis: effects on macular morphology and function. 61
31149861 2019
144
Sexual Experience before Treatment for Vaginal Agenesis: A Retrospective Review of 137 Women. 61
30582973 2019
145
The accuracy of static vs. dynamic computer-assisted implant surgery in single tooth space: A randomized controlled trial. 61
31060099 2019
146
Initial assessment of a child with suspected disorder of sex development. 61
31105293 2019
147
Pain Relieving Effect of-NSAIDs-CAIs Hybrid Molecules: Systemic and Intra-Articular Treatments against Rheumatoid Arthritis. 61
31003542 2019
148
Molecular diagnostics of disorders of sexual development: an Indian survey and systems biology perspective. 61
30550360 2019
149
New mutation causing androgen insensitivity syndrome - a case report and review of literature. 61
30449224 2019
150
Different Clinical Presentations and Management in Complete Androgen Insensitivity Syndrome (CAIS). 61
30970592 2019
151
Complete Androgen Insensitivity Syndrome: Successful Laparoscopic Management. 61
30956493 2019
152
Genetic Analysis Reveals Complete Androgen Insensitivity Syndrome in Female Children Surgically Treated for Inguinal Hernia. 61
31012339 2019
153
[Analysis of AR gene variant in an infant with complete androgen insensitivity syndrome]. 61
30950026 2019
154
Gonadoblastoma Y locus genes expressed in germ cells of individuals with dysgenetic gonads and a Y chromosome in their karyotypes include DDX3Y and TSPY. 61
30753444 2019
155
Severe forms of complete androgen insensitivity syndrome caused by a p.Q65X novel mutation in androgen receptor: Clinical manifestations, imaging findings and molecular genetics. 61
30742848 2019
156
Uterus transplantation in patients with complete androgen insensitivity syndrome (CAIS): Why CAIS cannot be considered as an indication in France. 61
30553052 2019
157
Malignant Leydig Cell Tumor in Elderly Complete Androgen Insensitivity Patient: A Case Report. 61
31477948 2019
158
Review: Therapeutic potential of carbonic anhydrase inhibitors. 61
31081787 2019
159
The evolution of the axial skeleton intercentrum system in snakes revealed by new data from the Cretaceous snakes Dinilysia and Najash. 61
30718525 2019
160
Androgen Insensitivity Syndrome: Clinical Phenotype and Molecular Analysis in a Single Tertiary Center Cohort 61
30251955 2019
161
Retrospective cohort study exploring whether an association exists between spatial distribution of cystoid spaces in cystoid macular oedema secondary to retinitis pigmentosa and response to treatment with carbonic anhydrase inhibitors. 61
29706600 2019
162
Sex assignment practice in disorders of sexual differentiation: survey results from paediatric endocrinologists in the Arab region. 61
30864373 2019
163
Concurrent bilateral testicular hamartomas and serous borderline tumors in a patient with complete androgen insensitivity syndrome: a case report and review of the literature. 61
31934001 2019
164
The Sexual Differentiation of the Human Brain: Role of Sex Hormones Versus Sex Chromosomes. 61
30599078 2019
165
North American cost analysis of brand name versus generic drugs for the treatment of glaucoma. 61
31908505 2019
166
Carbonic Anhydrase Inhibitors of Different Structures Dilate Pre-Contracted Porcine Retinal Arteries. 61
30678227 2019
167
Selenols: a new class of carbonic anhydrase inhibitors. 61
30560259 2019
168
C-cinnamoyl Glycosides: An Emerging "Tail" for the Development of Selective Carbonic Anhydrase Inhibitors. 61
30009704 2019
169
State of the Art on Carbonic Anhydrase Modulators for Biomedical Purposes. 61
29932025 2019
170
Resolution of co-eluting isomers of anti-inflammatory drugs conjugated to carbonic anhydrase inhibitors from plasma in liquid chromatography by energy-resolved tandem mass spectrometry. 61
29536775 2018
171
Carbon- versus sulphur-based zinc binding groups for carbonic anhydrase inhibitors? 61
29390912 2018
172
Carbonic anhydrase inhibitors as emerging agents for the treatment and imaging of hypoxic tumors. 61
30426805 2018
173
Synthesis of different thio-scaffolds bearing sulfonamide with subnanomolar carbonic anhydrase II and IX inhibitory properties and X-ray investigations for their inhibitory mechanism. 61
30253337 2018
174
Crystal structure of the human carbonic anhydrase II adduct with 1-(4-sulfamoylphenyl-ethyl)-2,4,6-triphenylpyridinium perchlorate, a membrane-impermeant, isoform selective inhibitor. 61
29199489 2018
175
Discovering a new class of antifungal agents that selectively inhibits microbial carbonic anhydrases. 61
30284487 2018
176
4-Hydroxy-3-nitro-5-ureido-benzenesulfonamides Selectively Target the Tumor-Associated Carbonic Anhydrase Isoforms IX and XII Showing Hypoxia-Enhanced Antiproliferative Profiles. 61
30433782 2018
177
Integrating clinical and genetic approaches in the diagnosis of 46,XY disorders of sex development. 61
30496128 2018
178
Two Korean girls with complete androgen insensitivity syndrome diagnosed in infancy. 61
30599484 2018
179
Cognitive abilities in women with complete androgen insensitivity syndrome and women with gonadal dysgenesis. 61
29884451 2018
180
Childhood Sex-Typed Behavior and Gender Change in Individuals with 46,XY and 46,XX Disorders of Sex Development: An Iranian Multicenter Study. 61
30128981 2018
181
Androgen receptor mRNA analysis from whole blood: a low-cost strategy for detection of androgen receptor gene splicing defects. 61
30193409 2018
182
Living with permanent infertility: A German study on attitudes toward motherhood in individuals with Complete Androgen Insensitivity Syndrome (CAIS) and Mayer-Rokitansky-Küster-Hauser Syndrome (MRKHS). 61
30362901 2018
183
D-dimer >2.785 μg/ml and multiple infarcts ≥3 vascular territories are two characteristics of identifying cancer-associated ischemic stroke patients. 61
30317943 2018
184
Group 5 ITI Consensus Report: Digital technologies. 61
30328201 2018
185
The accuracy of static computer-aided implant surgery: A systematic review and meta-analysis. 61
30328191 2018
186
Carbonic anhydrase inhibitors as antitumor/antimetastatic agents: a patent review (2008-2018). 61
30074415 2018
187
Oestrogen versus androgen in hormone-replacement therapy for complete androgen insensitivity syndrome: a multicentre, randomised, double-dummy, double-blind crossover trial. 61
30075954 2018
188
STRUCTURAL AND FUNCTIONAL MONITORING OF EXTRAMACULAR CYSTOID SPACES IN A CASE OF X-LINKED RETINOSCHISIS TREATED WITH ACETAZOLAMIDE. 61
27984356 2018
189
Static computer-aided implant surgery (s-CAIS) analysing patient-reported outcome measures (PROMs), economics and surgical complications: A systematic review. 61
30328203 2018
190
Mental health and sexual function in CAIS: context beyond sex hormones. 61
30075955 2018
191
Applications of carbonic anhydrases inhibitors in renal and central nervous system diseases. 61
30175635 2018
192
Complete androgen insensitivity syndrome caused by c.1769-1G > C mutation and activation of a cryptic splice acceptor site in the androgen receptor gene. 61
29859233 2018
193
Inhibition of carbonic anhydrases by a substrate analog: benzyl carbamate directly coordinates the catalytic zinc ion mimicking bicarbonate binding. 61
30140816 2018
194
Surface characteristics and antimicrobial properties of modified catheter surfaces by polypyrogallol and metal ions. 61
29853139 2018
195
Development of a high throughput yeast-based screening assay for human carbonic anhydrase isozyme II inhibitors. 61
30078153 2018
196
Identification of 4 novel mutations of androgen receptor gene in 8 Chinese families with complete androgen insensitivity syndrome. 61
29693241 2018
197
Complete Androgen Insensitivity Syndrome due to Mutations in the DNA-Binding Domain of the Human Androgen Receptor Gene. 61
30165367 2018
198
Functional and Structural Study of the Amino Acid Substitution in a Novel Familial Androgen Receptor Mutation (W752G) Responsible for Complete Androgen Insensitivity Syndrome. 61
30064134 2018
199
Diurnal variations of foveoschisis by optical coherence tomography in patients with RS1 X-linked juvenile retinoschisis. 61
29902095 2018
200
Sex Differences in Reproductive Hormones During Mini-Puberty in Infants With Normal and Disordered Sex Development. 61
29917083 2018
201
Carbonic anhydrase inhibition selectively prevents amyloid β neurovascular mitochondrial toxicity. 61
29873184 2018
202
Complete androgen insensitivity syndrome in a young woman with metabolic disorder and diabetes: A case report. 61
30113450 2018
203
A challenging case of primary amenorrhoea. 61
30002216 2018
204
Unraveling the discrepancies in size dependence of hardness and thermal stability in crystalline/amorphous nanostructured multilayers: Cu/Cu-Ti vs. Cu/HfO2. 61
30020297 2018
205
First evidence for silica condensation within the solar protoplanetary disk. 61
29967181 2018
206
4-Substituted Benzenesulfonamides Incorporating Bi/Tricyclic Moieties Act as Potent and Isoform-Selective Carbonic Anhydrase II/IX Inhibitors. 61
29912561 2018
207
Freezability and fertility of frozen-thawed boar semen supplemented with ostrich egg yolk lipoproteins. 61
30450863 2018
208
Genetic analysis of invasive Escherichia coli in Scotland reveals determinants of healthcare-associated versus community-acquired infections. 61
29932391 2018
209
Discovery of Novel Nonsteroidal Anti-Inflammatory Drugs and Carbonic Anhydrase Inhibitors Hybrids (NSAIDs-CAIs) for the Management of Rheumatoid Arthritis. 61
29746127 2018
210
Aberrant breast tissue in complete androgen insensitivity syndrome. 61
29388223 2018
211
Androgen insensitivity syndrome. 61
29949163 2018
212
Mental Health and Disorders of Sex Development/Intersex Conditions in Iranian Culture: Congenital Adrenal Hyperplasia, 5-α Reductase Deficiency-Type 2, and Complete Androgen Insensitivity Syndrome. 61
29294229 2018
213
A rare polypyrimidine tract mutation in the androgen receptor gene results in complete androgen insensitivity syndrome. 61
28857053 2018
214
Amino Acids as Building Blocks for Carbonic Anhydrase Inhibitors. 61
29795039 2018
215
Psychological well-being and workability in child abuse investigators. 61
29546431 2018
216
Carbonic anhydrase II does not exhibit Nitrite reductase or Nitrous Anhydrase Activity. 61
29355738 2018
217
Androgen insensitivity syndrome: a review. 61
29768628 2018
218
Prenatal testosterone and theory of mind development: Findings from disorders of sex development. 61
29398092 2018
219
Mismatch between fetal sexing and birth phenotype: a case of complete androgen insensitivity syndrome. 61
29118296 2018
220
Efficacy of additional topical betamethasone in persistent cystoid macular oedema after carbonic anhydrase inhibitor treatments in retinitis pigmentosa. 61
29657976 2018
221
Novel Variant of the Androgen Receptor Gene in a Patient With Complete Androgen Insensitivity Syndrome and Polyorchidism. 61
30705665 2018
222
Relationship between the Clinical Course of Ulcerative Colitis during Pregnancy and the Outcomes of Pregnancy: A Retrospective Evaluation. 61
29033411 2018
223
Management of Gonads in Adults with Androgen Insensitivity: An International Survey. 61
30336477 2018
224
Adrianite, Ca12(Al4Mg3Si7)O32Cl6, a new Cl-rich silicate mineral from the Allende meteorite: An alteration phase in a Ca-Al-rich inclusion. 61
30956279 2018
225
Asthma among Household Youth on Racial Minority Operated Farms-United States, 2008. 61
29648957 2018
226
Insights into the binding mode of sulphamates and sulphamides to hCA II: crystallographic studies and binding free energy calculations. 61
28738704 2017
227
Isatin: a privileged scaffold for the design of carbonic anhydrase inhibitors. 61
27775452 2017
228
Prenatal Diagnosis of Twin Fetuses with a Novel AR Gene Mutation in a Chinese Family of Complete Androgen Insensitivity Syndrome. 61
29206494 2017
229
A recurrent synonymous mutation in the human androgen receptor gene causing complete androgen insensitivity syndrome. 61
28743543 2017
230
Respiratory Syncytial Virus Infection Control Challenges with a Novel Polymerase Chain Reaction Assay in a Tertiary Medical Center. 61
29056109 2017
231
Frequency of gonadal tumours in complete androgen insensitivity syndrome (CAIS): A retrospective case-series analysis. 61
28351649 2017
232
Increased psychiatric morbidity in women with complete androgen insensitivity syndrome or complete gonadal dysgenesis. 61
28867417 2017
233
Clinical and genetic characterization of six cases with complete androgen insensitivity syndrome in China. 61
28947719 2017
234
Controversies of Sex Re-assignment in Genetic Males with Congenital Inadequacy of the Penis. 61
28687949 2017
235
[The Wish for a Child in the Case of (Permanent) Infertility: Development of the "German Questionnaire on Attitudes Toward Motherhood"]. 61
28719918 2017
236
1,3-Oxazole-based selective picomolar inhibitors of cytosolic human carbonic anhydrase II alleviate ocular hypertension in rabbits: Potency is supported by X-ray crystallography of two leads. 61
28728897 2017
237
Carbonic Anhydrase Inhibition and the Management of Hypoxic Tumors. 61
28926956 2017
238
Hormone replacement treatment choices in complete androgen insensitivity syndrome: an audit of an adult clinic. 61
28615185 2017
239
Bone mineral density in complete androgen insensitivity syndrome and the timing of gonadectomy. 61
28493277 2017
240
[Complete androgen insensitivity syndrome associated with vesical fistula: a case report and literature review]. 61
28816296 2017
241
Participation of adults with disorders/differences of sex development (DSD) in the clinical study dsd-LIFE: design, methodology, recruitment, data quality and study population. 61
28821302 2017
242
Complete androgen insensitivity syndrome and anti-Müllerian hormone levels before and after laparoscopic gonadectomy. 61
30254896 2017
243
AR mutations in 28 patients with androgen insensitivity syndrome (Prader grade 0-3). 61
28624954 2017
244
Using symptom and interference questionnaires to identify recovery among children with anxiety disorders. 61
27845527 2017
245
Mutational Analysis of Androgen Receptor Gene in Two Families with Androgen Insensitivity. 61
28670533 2017
246
Female with 46, XY karyotype. 61
28791271 2017
247
Sociodemographic profile of an Olympic team. 61
28501022 2017
248
Potential inhibitors of human carbonic anhydrase isozymes I and II: Design, synthesis and docking studies of new 1,3,4-thiadiazole derivatives. 61
28511907 2017
249
Effects of androgen receptor mutation on testicular histopathology of patient having complete androgen insensitivity. 61
28299491 2017
250
Is the Second to Fourth Digit Ratio (2D:4D) a Biomarker of Sex-Steroids Activity? 61
28613048 2017
251
Female phenotype with male karyotype: a clinical enigma. 61
28487303 2017
252
Sex Differences in White Matter Microstructure in the Human Brain Predominantly Reflect Differences in Sex Hormone Exposure. 61
27226438 2017
253
Gonadal tumour risk in 292 phenotypic female patients with disorders of sex development containing Y chromosome or Y-derived sequence. 61
27862157 2017
254
Role of testosterone and Y chromosome genes for the masculinization of the human brain. 61
28070912 2017
255
Incidence of Recurrence in Posterior Circulation Childhood Arterial Ischemic Stroke. 61
28114639 2017
256
Presence of Germ Cells in Disorders of Sex Development: Implications for Fertility Potential and Preservation. 61
27840018 2017
257
Incidence and predictors of epilepsy after pediatric arterial ischemic stroke. 61
28087825 2017
258
[Analysis of AR gene mutation in a family affected with complete androgen insensitivity syndrome using long chain RT-PCR]. 61
28186600 2017
259
Design and Synthesis of Novel Nonsteroidal Anti-Inflammatory Drugs and Carbonic Anhydrase Inhibitors Hybrids (NSAIDs-CAIs) for the Treatment of Rheumatoid Arthritis. 61
28075587 2017
260
Accounting Information Systems in Healthcare: A Review of the Literature. 61
28679921 2017
261
Inhibition of Bacterial Carbonic Anhydrases as a Novel Approach to Escape Drug Resistance. 61
28049405 2017
262
Bone Mineral Density in Women Living with Complete Androgen Insensitivity Syndrome and Intact Testes or Removed Gonads. 61
28715798 2017
263
Heterozygous Nonsense Mutation in the Androgen Receptor Gene Associated with Partial Androgen Insensitivity Syndrome in an Individual with 47,XXY Karyotype. 61
28456808 2017
264
Do sex differences in CEOAEs and 2D:4D ratios reflect androgen exposure? A study in women with complete androgen insensitivity syndrome. 61
28413602 2017
265
Sexual orientation and medical history among Iranian people with Complete Androgen Insensitivity Syndrome and Congenital Adrenal Hyperplasia. 61
27998513 2017
266
Effects of chromosomal sex and hormonal influences on shaping sex differences in brain and behavior: Lessons from cases of disorders of sex development. 61
27841933 2017
267
Update on the Pathophysiology and Risk Factors for the Development of Malignant Testicular Germ Cell Tumors in Complete Androgen Insensitivity Syndrome. 61
28719895 2017
268
Efficacy of carbonic anhydrase inhibitors in management of cystoid macular edema in retinitis pigmentosa: A meta-analysis. 61
29023491 2017
269
Functional Impact of Novel Androgen Receptor Mutations on the Clinical Manifestation of Androgen Insensitivity Syndrome. 61
29237170 2017
270
Gonadal Surgery in Complete Androgen Insensitivity Syndrome: A Debate. 61
28609774 2017
271
Gonadectomy in Complete Androgen Insensitivity Syndrome: Why and When? 61
28719904 2017
272
Complete Androgen Insensitivity Syndrome: A Problem-Based Learning Case. 61
30984864 2016
273
Complete androgen insensitivity syndrome with concomitant seminoma and Sertoli cell adenoma: an unusual combination. 61
28039344 2016
274
[The prenatal genetic diagnosis of a family with complete androgen insensitivity syndrome]. 61
28057092 2016
275
Obstructive Sleep-Disordered Breathing Is More Common than Central in Mild Familial Dysautonomia. 61
27655467 2016
276
Toxicity and Physiological Actions of Carbonic Anhydrase Inhibitors to Aedes aegypti and Drosophila melanogaster. 61
28025488 2016
277
Salts of 5-amino-2-sulfonamide-1,3,4-thiadiazole, a structural and analog of acetazolamide, show interesting carbonic anhydrase inhibitory properties, diuretic, and anticonvulsant action. 61
26497704 2016
278
Identification of an AR Mutation-Negative Class of Androgen Insensitivity by Determining Endogenous AR Activity. 61
27583472 2016
279
Carbonic Anhydrase Inhibitors for the Treatment of Cystic Macular Lesions in Children With X-Linked Juvenile Retinoschisis. 61
27699410 2016
280
Uterus transplantation in France: for which patients? 61
27552172 2016
281
Malignancy in disorders of sex development. 61
27785439 2016
282
Complete Androgen Insensitivity Syndrome in Three Generations of Indian Pedigree. 61
27651630 2016
283
Complete androgen insensitivity syndrome caused by a deep intronic pseudoexon-activating mutation in the androgen receptor gene. 61
27609317 2016
284
Primitive Solar System materials and Earth share a common initial (142)Nd abundance. 61
27629644 2016
285
Quantitative Characterization of the Interaction Space of the Mammalian Carbonic Anhydrase Isoforms I, II, VII, IX, XII, and XIV and their Inhibitors, Using the Proteochemometric Approach. 61
26990115 2016
286
Carbonic anhydrase inhibition and the management of neuropathic pain. 61
27211329 2016
287
Carbonic anhydrase inhibitors: a review on the progress of patent literature (2011-2016). 61
27387065 2016
288
The history and rationale of using carbonic anhydrase inhibitors in the treatment of peptic ulcers. In memoriam Ioan Puşcaş (1932-2015). 61
26108882 2016
289
[Female-typical neural activation in women with complete androgen insensitivity syndrome]. 61
27615164 2016
290
"It's Part of Me, Not All of Me": Young Women's Experiences of Receiving a Diagnosis Related to Diverse Sex Development. 61
26639995 2016
291
Timing of Gonadectomy in Patients with Complete Androgen Insensitivity Syndrome-Current Recommendations and Future Directions. 61
26428189 2016
292
Refractory diversion neovaginitis in a sigmoid-colon-derived neovagina: clinical and histopathological considerations. 61
28839860 2016
293
Active Components of Essential Oils as Anti-Obesity Potential Drugs Investigated by in Silico Techniques. 61
27268752 2016
294
Non-Classical Inhibition of Carbonic Anhydrase. 61
27438828 2016
295
Structure and function of carbonic anhydrases. 61
27407171 2016
296
Laparoscopic Gonadectomy and Hernia Repair for Complete Androgen Insensitivity Syndrome (CAIS): A Rare Cause of Primary Amenorrhea. 61
27298532 2016
297
Surgery in disorders of sex development (DSD) with a gender issue: If (why), when, and how? 61
27132944 2016
298
Mutational analysis of the androgen receptor gene in two Chinese families with complete androgen insensitivity syndrome. 61
27284311 2016
299
Clinical, hormonal and radiological profile of 46XY disorders of sexual development. 61
27186544 2016
300
Neural Activation During Mental Rotation in Complete Androgen Insensitivity Syndrome: The Influence of Sex Hormones and Sex Chromosomes. 61
25452569 2016
301
Accretion timescales and style of asteroidal differentiation in an 26Al-poor protoplanetary disk. 61
27445415 2016
302
Sulfonamides incorporating heteropolycyclic scaffolds show potent inhibitory action against carbonic anhydrase isoforms I, II, IX and XII. 61
26796953 2016
303
Discovery of 2-azetidinone and 1H-pyrrole-2,5-dione derivatives containing sulfonamide group at the side chain as potential cholesterol absorption inhibitors. 61
26783178 2016
304
The contribution of the androgen receptor (AR) in human spatial learning and memory: A study in women with complete androgen insensitivity syndrome (CAIS). 61
26522496 2016
305
The carbonic anhydrase inhibitor methazolamide prevents amyloid beta-induced mitochondrial dysfunction and caspase activation protecting neuronal and glial cells in vitro and in the mouse brain. 61
26581638 2016
306
Gender Role, Gender Identity and Sexual Orientation in CAIS ("XY-Women") Compared With Subfertile and Infertile 46,XX Women. 61
26133743 2016
307
Gonadal malignancy in 202 female patients with disorders of sex development containing Y-chromosome material. 61
26608236 2016
308
Complete androgen insensitivity syndrome or testicular feminization: review of literature based on a case report. 61
28270903 2016
309
Complete androgen insensitivity syndrome caused by a novel splice donor site mutation and activation of a cryptic splice donor site in the androgen receptor gene. 61
26435450 2016
310
Complete androgen insensitivity syndrome associated with bilateral sertoli cell adenomas and unilateral paratesticular leiomyoma: A case report. 61
29090880 2016
311
A Recurrent Germline Mutation in the 5'UTR of the Androgen Receptor Causes Complete Androgen Insensitivity by Activating Aberrant uORF Translation. 61
27110943 2016
312
Drug interaction considerations in the therapeutic use of carbonic anhydrase inhibitors. 61
26878088 2016
313
How many carbonic anhydrase inhibition mechanisms exist? 61
26619898 2016
314
Fluorescent sulfonamide carbonic anhydrase inhibitors incorporating 1,2,3-triazole moieties: Kinetic and X-ray crystallographic studies. 61
26682703 2016
315
Multicomponent chemistry in the synthesis of carbonic anhydrase inhibitors. 61
27784162 2016
316
Synthesis and carbonic anhydrase inhibitory activities of new thienyl-substituted pyrazoline benzenesulfonamides. 61
27435177 2016
317
N-glycosyl-N-hydroxysulfamides as potent inhibitors of Brucella suis carbonic anhydrases. 61
25792504 2015
318
Use of chondral fragments for one stage cartilage repair: A systematic review. 61
26716098 2015
319
Inorganic-organic solar cells based on quaternary sulfide as absorber materials. 61
26553746 2015
320
Post stroke hemi-dystonia in children: a neglected area of research. 61
26660977 2015
321
Androgen insensitivity syndrome in a cohort of Sri Lankan children with 46, XY disorders of sex development (46, XY DSD). 61
26778393 2015
322
Keratitis in six dogs after topical treatment with carbonic anhydrase inhibitors for glaucoma. 61
26642138 2015
323
A novel mutation of the androgen receptor gene in familial complete androgen insensitivity syndrome. 61
26592841 2015
324
A novel insA2933 causes premature termination of translation and is accompanied by overexpression of truncated androgen receptor gene in a patient with complete androgen insensitivity syndrome. 61
25997614 2015
325
New natural product carbonic anhydrase inhibitors incorporating phenol moieties. 61
26498393 2015
326
Quantitative Evaluation of Female Pattern Hair Loss in Chinese Women: A Preliminary Study. 61
26372122 2015
327
Gonadal malignancy risk and prophylactic gonadectomy in disorders of sexual development. 61
25879315 2015
328
Covalent-Allosteric Kinase Inhibitors. 61
26110718 2015
329
Hydroxylamine-O-sulfonamide is a versatile lead compound for the development of carbonic anhydrase inhibitors. 61
26094945 2015
330
Exploring carbonic anhydrase inhibition with multimeric coumarins displayed on a fullerene scaffold. 61
26058669 2015
331
Allocation Games: Addressing the Ill-Posed Nature of Allocation in Life-Cycle Inventories. 61
26061700 2015
332
Elevated testosterone levels in a racing horse due to an XY testicular disorder of sexual development. 61
26281448 2015
333
Quality of Life and Psychological Adjustment of Women Living with 46,XY Differences of Sex Development. 61
25893774 2015
334
Early accretion of protoplanets inferred from a reduced inner solar system 26Al inventory. 61
27429474 2015
335
Early aqueous activity on the ordinary and carbonaceous chondrite parent bodies recorded by fayalite. 61
26100451 2015
336
Constraints on the formation environment of two chondrule-like igneous particles from Comet 81P/Wild 2. 61
31031558 2015
337
Recent advances in the discovery of zinc-binding motifs for the development of carbonic anhydrase inhibitors. 61
24939097 2015
338
X-ray crystallography-promoted drug design of carbonic anhydrase inhibitors. 61
25813715 2015
339
Chromosomal Study is Must for Prepubertal Girl with Inguinal Hernia: Opportunity to Diagnose Complete Androgen Insensitivity Syndrome. 61
26023570 2015
340
[Analysis of androgen receptor gene mutation in complete androgen insensitivity syndrome in a Uygur family]. 61
26081505 2015
341
[Complete androgen insensitivity syndrome]. 61
26012135 2015
342
Autocrine androgen action is essential for Leydig cell maturation and function, and protects against late-onset Leydig cell apoptosis in both mice and men. 61
25404712 2015
343
A review of the pharmacology of carbonic anhydrase inhibitors for the treatment of glaucoma in dogs and cats. 61
25660816 2015
344
Different types of androgen receptor mutations in patients with complete androgen insensitivity syndrome. 61
25674389 2015
345
[Complete androgen insensitivity syndrome: report of two cases and review of literature]. 61
26301004 2015
346
Usefulness and role of magnetic resonance imaging in a case of complete androgen insensitivity syndrome. 61
27398128 2015
347
Assessment of women who applied for the uterine transplant project as potential candidates for uterus transplantation. 61
25226847 2015
348
A Cross-Section Study of the Ontogeny of Gender Roles in Women with DSD. 61
25938375 2015
349
Complete androgen insensitivity syndrome associated with male gender identity or female precocious puberty in the same family. 61
25633053 2015
350
Acetazolamide for the treatment of idiopathic intracranial hypertension. 61
26154918 2015
351
Evidence for nucleosynthetic enrichment of the protosolar molecular cloud core by multiple supernova events. 61
25684790 2015
352
Characteristic features of reproductive hormone profiles in late adolescent and adult females with complete androgen insensitivity syndrome. 61
25613104 2015
353
[Inguinal hernias in girls: is caryotype necessary?]. 61
25799663 2015
354
Carbonic anhydrase inhibitors: guaiacol and catechol derivatives effectively inhibit certain human carbonic anhydrase isoenzymes (hCA I, II, IX and XII). 61
25373500 2015
355
An Overview of the Selectivity and Efficiency of the Bacterial Carbonic Anhydrase Inhibitors. 61
25312213 2015
356
Youth on racial minority operated U.S. farms, 2008: demographics and injuries. 61
25453180 2014
357
A case of complete androgen insensitivity syndrome: genetic analysis of the family. 61
25404833 2014
358
Brain responses to sexual images in 46,XY women with complete androgen insensitivity syndrome are female-typical. 61
25284435 2014
359
Complete androgen insensitivity syndrome with a Sertoli-Leydig cell tumor. 61
24333107 2014
360
Complete androgen insensitivity syndrome in juveniles and adults with female phenotypes. 61
25170741 2014
361
An update on surgical and non-surgical treatments for vaginal hypoplasia. 61
24899229 2014
362
Synthesis of a new series of N⁴-substituted 4-(2-aminoethyl)benzenesulfonamides and their inhibitory effect on human carbonic anhydrase cytosolic isozymes I and II and transmembrane tumor-associated isozymes IX and XII. 61
25016228 2014
363
Inhibition of mammalian carbonic anhydrases I-XIV with grayanotoxin III: solution and in silico studies. 61
23914927 2014
364
Androgen receptor phosphorylation: biological context and functional consequences. 61
24424504 2014
365
Otoacoustic emissions, auditory evoked potentials and self-reported gender in people affected by disorders of sex development (DSD). 61
25038289 2014
366
Increased risk of gonadal malignancy and prophylactic gonadectomy: a study of 102 phenotypic female patients with Y chromosome or Y-derived sequences. 61
24826988 2014
367
Laparoscopic gonedectomy in a case of complete androgen insensitivity syndrome. 61
25395750 2014
368
Malignant ovarian germ cell tumor - role of surgical staging and gonadal dysgenesis. 61
24836278 2014
369
A novel compound heterozygous mutation of the luteinizing hormone receptor -implications for fertility. 61
24849377 2014
370
AR and SRD5A2 gene mutations in a series of 51 Turkish 46,XY DSD children with a clinical diagnosis of androgen insensitivity. 61
24737579 2014
371
Prenatal diagnosis of sex chromosome aneuploidies and disorders of sex development--a retrospective analysis of 11-year data. 61
24445234 2014
372
Occurrence of extended-spectrum b-lactamase producers among enterobacteriaceae in a paediatric tertiary care facility in Kabul. 61
25052982 2014
373
Dominant behaviours in the expression of human carbonic anhydrase hCA I activity. 61
24919797 2014
374
Carbonic anhydrase inhibitors. Synthesis of a novel series of 5-substituted 2,4-dichlorobenzenesulfonamides and their inhibition of human cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII. 61
24871996 2014
375
A case report of urethral prolapse in a 38 year old female with 46XY karyotype. 61
25017598 2014
376
Bilateral Sertoli cell adenoma in gonads, associated with serous cystadenoma. 61
25119177 2014
377
Differentiating Swyer syndrome and complete androgen insensitivity syndrome: a diagnostic dilemma. 61
24119655 2014
378
Complete androgen insensitivity syndrome: factors influencing gonadal histology including germ cell pathology. 61
24186138 2014
379
Long-term outcomes of vaginoplasty with autologous buccal micromucosa. 61
24785845 2014
380
Bilateral laparoscopic gonadectomy in a patient with complete androgen insensitivity syndrome and bilateral sertoli-leydig cell tumor: a case report and brief review of the literature. 61
25032133 2014
381
Testicular histological and immunohistochemical aspects in a post-pubertal patient with 5 alpha-reductase type 2 deficiency: case report and review of the literature in a perspective of evaluation of potential fertility of these patients. 61
24885102 2014
382
Carbonic anhydrase inhibitors in corneal endothelial transport. 61
24667858 2014
383
Complete androgen insensitivity syndrome with a large gonadal serous papillary cystadenofibroma. 61
25191030 2014
384
Sexual life and sexual wellness in individuals with complete androgen insensitivity syndrome (CAIS) and Mayer-Rokitansky-Küster-Hauser Syndrome (MRKHS). 61
24165016 2014
385
Design, synthesis and evaluation of N-substituted saccharin derivatives as selective inhibitors of tumor-associated carbonic anhydrase XII. 61
24560739 2014
386
Discovering isozyme-selective inhibitor scaffolds of human carbonic anhydrases using structural alignment and de novo drug design approaches. 61
24112770 2014
387
Gonocyte transformation to spermatogonial stem cells occurs earlier in patients with undervirilisation syndromes. 61
24528977 2014
388
The child anxiety impact scale: examining parent- and child-reported impairment in child anxiety disorders. 61
23915200 2014
389
Glaucoma and the applications of carbonic anhydrase inhibitors. 61
24146387 2014
390
A novel mutation (c.2735_2736delTC) in the androgen receptor gene in 46,XY females with complete androgen insensitivity syndrome in an Egyptian family. 61
25034089 2014
391
Sex hormone replacement in disorders of sex development. 61
25247652 2014
392
Response to: Comment on "Complete Androgen Insensitivity Syndrome: Optimizing Diagnosis and Management". 61
25574409 2014
393
Testicular feminization: complete androgen insensitivity syndrome. Discussions based on a case report. 61
24715185 2014
394
[Androgen insensitivity syndrome - case report]. 61
24635364 2014
395
Comment on "complete androgen insensitivity syndrome: optimizing diagnosis and management". 61
24949207 2014
396
Complete androgen insensitivity syndrome in three sisters. 61
24520507 2014
397
Diagnostic laparoscopy in a twelve year old girl with right iliac fossa pain: A life changing diagnosis of complete androgen insensitivity syndrome. 61
24995665 2014
398
Hydrophobic substituents of the phenylmethylsulfamide moiety can be used for the development of new selective carbonic anhydrase inhibitors. 61
25258712 2014
399
Carbonic anhydrase inhibitors drug design. 61
24146385 2014
400
Structure-based screening for the discovery of new carbonic anhydrase VII inhibitors. 61
24287559 2014
401
L712V mutation in the androgen receptor gene causes complete androgen insensitivity syndrome due to severe loss of androgen function. 61
24055831 2013
402
A novel arg616Cys mutation in the DNA-binding domain of complete androgen insensitivity syndrome in a Chinese family. 61
24229697 2013
403
Structural study of interaction between brinzolamide and dorzolamide inhibition of human carbonic anhydrases. 61
24090602 2013
404
Evidence for supernova injection into the solar nebula and the decoupling of r-process nucleosynthesis. 61
24101483 2013
405
Incidence of infectious complications associated with central venous catheters in pediatric population. 61
23422229 2013
406
Complexities of gender assignment in 17β-hydroxysteroid dehydrogenase type 3 deficiency: is there a role for early orchiectomy? 61
24025597 2013
407
Androgen receptor (AR) physiological roles in male and female reproductive systems: lessons learned from AR-knockout mice lacking AR in selective cells. 61
23782840 2013
408
Sarcoidosis patient: an unexpected reaction to carbonic anhydrase enzyme inhibitor. 61
23893285 2013
409
Genetic analysis of a family with complete androgen insensitivity syndrome. 61
24339553 2013
410
Evaluation of retained testes in adolescent girls and women with complete androgen insensitivity syndrome. 61
23533290 2013
411
Exploiting the hydrophobic and hydrophilic binding sites for designing carbonic anhydrase inhibitors. 61
23627619 2013
412
Critical evaluation of outcome scales assessment of lateral ankle ligament reconstruction. 61
23478889 2013
413
Evaluation of adverse events in self-reported sulfa-allergic patients using topical carbonic anhydrase inhibitors. 61
23445203 2013
414
182Hf-182W age dating of a 26Al-poor inclusion and implications for the origin of short-lived radioisotopes in the early Solar System. 61
23671077 2013
415
Intestinal-type endocervical adenocarcinoma in situ: an immunophenotypically distinct subset of AIS affecting older women. 61
23552379 2013
416
Novel mutation among two sisters with 17β hydroxysteroid dehydrogenase type 3 deficiency. 61
23375913 2013
417
"Bird-Wing" abdominal phalloplasty: A novel surgical technique for penile reconstruction. 61
23798805 2013
418
Screening for complete androgen insensitivity syndrome in girls with inguinal hernia: parental insight. 61
23418035 2013
419
Complete androgen insensitivity syndrome with persistent müllerian remnants. A case report. 61
22682968 2013
420
Secondary/tertiary benzenesulfonamides with inhibitory action against the cytosolic human carbonic anhydrase isoforms I and II. 61
22380772 2013
421
Analysis of saponins and phenolic compounds as inhibitors of α-carbonic anhydrase isoenzymes. 61
22299585 2013
422
Structural effect of phenyl ring compared to thiadiazole based adamantyl-sulfonamides on carbonic anhydrase inhibition. 61
23490152 2013
423
Kinetic and in silico analysis of thiazolidin-based inhibitors of α-carbonic anhydrase isoenzymes. 61
23173744 2013
424
Glycosidic carbonic anhydrase IX inhibitors: a sweet approach against cancer. 61
23199483 2013
425
Mono-/dihydroxybenzoic acid esters and phenol pyridinium derivatives as inhibitors of the mammalian carbonic anhydrase isoforms I, II, VII, IX, XII and XIV. 61
22668600 2013
426
Evaluation of a modified Broström-Gould procedure for treatment of chronic lateral ankle instability: A retrospective study with critical analysis of outcome scoring. 61
23337275 2013
427
[Identification of a novel frameshift mutation of human androgen receptor gene in a patient featuring complete androgen insensitivity syndrome]. 61
23450491 2013
428
Complete androgen insensitivity syndrome associated with bilateral Sertoli cell adenomas and paratesticular leiomyomas: case report and review of the literature. 61
22819761 2013
429
Association of ocular hypotensive medication types with dynamic contour tonometry and Goldmann applanation tonometry measurements in a glaucoma and ocular hypertensive population. 61
23066787 2013
430
Glaucoma medications. 61
23505792 2013
431
Antiglaucoma carbonic anhydrase inhibitors: a patent review. 61
23627893 2013
432
Complete androgen insensitivity syndrome and discordant Müllerian remnants: two cases with novel mutation in the androgen receptor. 61
23729616 2013
433
A novel mutation (c.T3816 > C) in the androgen receptor gene in a 46,XY female patient with androgen insensitivity syndrome. 61
24186597 2013
434
Complete androgen insensitivity syndrome: a rare case of disorder of sex development. 61
23533861 2013
435
Role of imaging in the diagnosis and management of complete androgen insensitivity syndrome in adults. 61
23762728 2013
436
A large seminoma occurring 20 years after diagnosis of complete androgen insensitivity syndrome: A case report. 61
24371685 2013
437
Androgen insensitivity syndrome. 61
22812659 2013
438
Minor hypospadias: the "tip of the iceberg" of the partial androgen insensitivity syndrome. 61
23637914 2013
439
The introduction and evaluation of mobile devices to improve access to patient records: a catalyst for innovation and collaboration at BCCA. 61
23388289 2013
440
Carbonic anhydrase inhibitors: an editorial. 61
23461558 2013
441
Anticonvulsant/antiepileptic carbonic anhydrase inhibitors: a patent review. 61
23514045 2013
442
Advances in the Surgical Management of Articular Cartilage Defects: Autologous Chondrocyte Implantation Techniques in the Pipeline. 61
26069648 2013
443
Diuretics with carbonic anhydrase inhibitory action: a patent and literature review (2005 - 2013). 61
23488823 2013
444
Potentiation of the effect of thiazide derivatives by carbonic anhydrase inhibitors: molecular mechanisms and potential clinical implications. 61
24260196 2013
445
Lessons learned from a community-academic initiative: the development of a core competency-based training for community-academic initiative community health workers. 61
22594730 2012
446
Dorzolamide-induced relaxation of intraocular porcine ciliary arteries in vitro depends on nitric oxide and the vascular endothelium. 61
22816608 2012
447
Carbonic anhydrase inhibitors: inhibition of human and bovine isoenzymes by benzenesulphonamides, cyclitols and phenolic compounds. 61
21999604 2012
448
Structure-based drug discovery of carbonic anhydrase inhibitors. 61
22468747 2012
449
Complete androgen insensitivity syndrome. 61
24293884 2012
450
Laparoscopy versus ultrasonography for the evaluation of Mullerian structures in children with complex disorders of sex development. 61
23064803 2012
451
XY Female with Complete Androgen Insensitivity Syndrome with Bilateral Inguinal Hernia. 61
24293881 2012
452
Heterocyclic compounds as carbonic anhydrase inhibitor. 61
21981003 2012
453
Management of vaginal agenesis. 61
21872517 2012
454
Patients with disorders of sex development (DSD) at risk of gonadal tumour development: management based on laparoscopic biopsy and molecular diagnosis. 61
22540217 2012
455
How do Individuals with Complete Androgen Insensitivity Syndrome, Mayer-Rokitansky-Küster-Hauser Syndrome or Polycystic Ovary Syndrome Experience Contact to Other Affected Persons? 61
25258457 2012
456
Gender identity and gender role orientation in female assigned patients with disorders of sex development. 61
22999536 2012
457
Quality of life evaluation in juveniles with disorders of sexual development. 61
23053598 2012
458
Topical drug delivery to the eye: dorzolamide. 61
22269010 2012
459
The absolute chronology and thermal processing of solids in the solar protoplanetary disk. 61
23118187 2012
460
Antibacterial and antifouling catheter coatings using surface grafted PEG-b-cationic polycarbonate diblock copolymers. 61
22748920 2012
461
An exploration of young women's experiences of living with excess weight. 61
22134062 2012
462
In vitro and in vivo effects of some benzodiazepine drugs on human and rabbit erythrocyte carbonic anhydrase enzymes. 61
21919687 2012
463
Androgen insensitivity syndrome. 61
23044881 2012
464
A novel nonsense mutation in the N-terminal domain of the androgen receptor gene causes complete androgen insensitivity syndrome. 61
22943730 2012
465
In vivo imaging reveals novel aspects of retinal disease progression in Rs1h(-/Y) mice but no therapeutic effect of carbonic anhydrase inhibition. 61
22672048 2012
466
Umbilical KeyPort bilateral laparoscopic orchiectomy in patient with complete androgen insensitivity syndrome. 61
23131511 2012
467
Hydroxamate represents a versatile zinc binding group for the development of new carbonic anhydrase inhibitors. 61
22836518 2012
468
Update on carbonic anhydrase inhibitors: a patent review (2008 - 2011). 61
22788994 2012
469
Methazolamide is a new hepatic insulin sensitizer that lowers blood glucose in vivo. 61
22586591 2012
470
Sway activity and muscle recruitment order during transition from double to single-leg stance in subjects with chronic ankle instability. 61
22727049 2012
471
Sulfonamides: a patent review (2008 - 2012). 61
22697257 2012
472
Novel androgen receptor gene mutation in patient with complete androgen insensitivity syndrome. 61
22608796 2012
473
Timing of gonadectomy in adult women with complete androgen insensitivity syndrome (CAIS): patient preferences and clinical evidence. 61
22211628 2012
474
A large deletion/insertion-induced frameshift mutation of the androgen receptor gene in a family with a familial complete androgen insensitivity syndrome. 61
22487869 2012
475
Standardized assessment of new electromagnetic field generators in an interventional radiology setting. 61
22755722 2012
476
A novel nonsense mutation in the androgen receptor gene causes the complete androgen insensitivity syndrome. 61
21757511 2012
477
Meta-analysis of α2-adrenergic agonists versus carbonic anhydrase inhibitors as adjunctive therapy. 61
22321008 2012
478
The use of mouth brushings for screening girls who present with inguinal hernia for complete androgen insensitivity syndrome. 61
22517520 2012
479
Particulated articular cartilage: CAIS and DeNovo NT. 61
22624244 2012
480
Carbonic anhydrase inhibitors as emerging drugs for the treatment of obesity. 61
22335448 2012
481
Satisfaction with genital surgery and sexual life of adults with XY disorders of sex development: results from the German clinical evaluation study. 61
22090272 2012
482
Ultrasound findings in a rare case of inguinal testicular torsion in a female with complete androgen insensitivity syndrome. 61
21998027 2012
483
A case of complete androgen insensitivity syndrome with a novel androgen receptor mutation. 61
23329762 2012
484
Developing the Coach Analysis and Intervention System (CAIS): establishing validity and reliability of a computerised systematic observation instrument. 61
22141459 2012
485
Sertoli cell tumor and intratubular germ cell neoplasia located in separate gonads in an adolescent patient with complete androgen insensitivity: a case report and review of literature. 61
22876554 2012
486
Intestinal sterol transporters and cholesterol absorption inhibition. 61
22101558 2011
487
Critical review of self-reported functional ankle instability measures. 61
22381198 2011
488
Carbonic anhydrase inhibitors: X-ray crystallographic studies for the binding of N-substituted benzenesulfonamides to human isoform II. 61
21952494 2011
489
Challenges in clinical and laboratory diagnosis of androgen insensitivity syndrome: a case report. 61
21902827 2011
490
Complete androgen insensitivity syndrome: an anatomic evaluation and sexual function questionnaire pilot study. 61
20719566 2011
491
Some psychometric properties of the Spanish version of the Clarity of Auditory Imagery Scale. 61
22049656 2011
492
In vitro inhibition of α-carbonic anhydrase isozymes by some phenolic compounds. 61
21669522 2011
493
The case reported as bilateral Sertoli-Leydig cell tumors in a 61-year-old woman with uterine aplasia may instead represent complete androgen insensitivity syndrome. 61
21623193 2011
494
Outcomes after a single-stage procedure for cell-based cartilage repair: a prospective clinical safety trial with 2-year follow-up. 61
21460066 2011
495
A large advanced seminoma in an older woman with androgen insensitivity syndrome. 61
22384429 2011
496
Male gender identity in complete androgen insensitivity syndrome. 61
20358272 2011
497
Clinical and genetic characterization of complete androgen insensitivity syndrome in a Chinese family. 61
21710452 2011
498
Muscular coactivation (CA) around the knee reduces power production in elderly women. 61
20546948 2011
499
Virtual screening-driven identification of human carbonic anhydrase inhibitors incorporating an original, new pharmacophore. 61
21420862 2011
500
[A novel mutation Glu441stop (GAA to TAA) of androgen receptor gene resulting in complete androgen insensitivity syndrome]. 61
21462130 2011
501
Gonadal structures in a fetus with complete androgen insensitivity syndrome and persistent Müllerian derivatives: comparison with normal fetal development. 61
20971460 2011
502
Oxygen isotope variations at the margin of a CAI records circulation within the solar nebula. 61
21385711 2011
503
Kinetic and docking studies of phenol-based inhibitors of carbonic anhydrase isoforms I, II, IX and XII evidence a new binding mode within the enzyme active site. 61
21282059 2011
504
A novel Arg615Ser mutation of androgen receptor DNA-binding domain in three 46,XY sisters with complete androgen insensitivity syndrome and bilateral inguinal hernia. 61
20888558 2011
505
Outbreak: the changing epidemiology of HAIs and CAIs. 61
21309345 2011
506
Androgen receptor mutations are associated with altered epigenomic programming as evidenced by HOXA5 methylation. 61
21311178 2011
507
Bilateral gonadal cysts and late diagnosis of androgen insensitivity syndrome treated by laparoscopic gonadectomy. 61
22567497 2011
508
Androgen-dependent measurements of female genitalia in women with complete androgen insensitivity syndrome. 61
21197679 2011
509
Complete androgen insensitivity syndrome with microtia: a rare presentation. 61
21264665 2011
510
Hormonal management of complete androgen insensitivity syndrome from adolescence onward. 61
22156544 2011
511
The Economic Feasibility of Canine-Assisted Interventions (CAIs) on the Health and Social Care of Older People Residing in Long Term Care: A Systematic Review. 61
27819975 2011
512
The effects of Canine-Assisted Interventions (CAIs) on the health and social care of older people residing in long term care: a systematic review. 61
27820064 2011
513
The Appropriateness of Canine-Assisted Interventions (CAIs) on the Health and Social Care of Older People Residing in Long Term Care: A Systematic Review. 61
27820161 2011
514
The meaningfulness of Canine-Assisted Interventions (CAIs) on the health and social care of older people residing in long term care: a systematic review. 61
27820415 2011
515
Teleoncology uptake in British Columbia. 61
21335743 2011
516
An ontology-based comparative anatomy information system. 61
21146377 2011
517
Adaptive feedback and student behaviour in computer-assisted instruction. 61
21070344 2010
518
Gender outcome in 46,XY complete androgen insensitivity syndrome: comment on T'Sjoen et al. (2010). 61
20552263 2010
519
[A novel deletion mutation in AR gene causes complete androgen insensitivity syndrome in a Chinese family]. 61
21154321 2010
520
A novel androgen receptor gene mutation in a Chinese patient with complete androgen insensitivity syndrome. 61
20833465 2010
521
Spiroimidazolidinone NPC1L1 inhibitors. Part 2: structure-activity studies and in vivo efficacy. 61
21030254 2010
522
The role of androgens in fetal growth: observational study in two genetic models of disordered androgen signalling. 61
20547585 2010
523
Familial complete androgen insensitivity syndrome with prostatic tissue and seminal vesicles. 61
20602105 2010
524
Androgen insensitivity syndrome (or Morris syndrome) and other associated pathologies. 61
21284344 2010
525
C601S mutation in the androgen receptor results in partial loss of androgen function. 61
20493947 2010
526
Vaginal replacement in the pediatric age group: a 34-year experience of intestinal vaginoplasty in children and young girls. 61
20920736 2010
527
Injury surveillance for youth on farms in the U.S., 2006. 61
21180351 2010
528
Cyclodextrin solubilization of carbonic anhydrase inhibitor drugs: formulation of dorzolamide eye drop microparticle suspension. 61
20637867 2010
529
Carbonic anhydrase inhibitors. Antioxidant polyphenols effectively inhibit mammalian isoforms I-XV. 61
20674354 2010
530
Severe neutropenia at time of port insertion is not a risk factor for catheter-associated infections in children with acute lymphoblastic leukemia. 61
20564151 2010
531
The efficacy of attendance and semi-attendance group cognitive-behavioral therapy (CBT) on the anxiety disorders of adolescent girls. 61
21526093 2010
532
Bone health in disorders of sex differentiation. 61
20820111 2010
533
Polyamines inhibit carbonic anhydrases by anchoring to the zinc-coordinated water molecule. 61
20590092 2010
534
Promising complexes of acetazolamide for topical ocular administration. 61
20565335 2010
535
Complete androgen insensitivity syndrome is frequently due to premature stop codons in exon 1 of the androgen receptor gene: an international collaborative report of 13 new mutations. 61
19463997 2010
536
Topical carbonic anhydrase inhibitors and visual function in glaucoma and ocular hypertension. 61
20350146 2010
537
Carbonic anhydrase inhibitors. 61
20529676 2010
538
S578N mutation of the androgen receptor in an adolescent with complete androgen insensitivity syndrome. 61
20819612 2010
539
Carbonic anhydrase inhibitors: crystallographic and solution binding studies for the interaction of a boron-containing aromatic sulfamide with mammalian isoforms I-XV. 61
20472429 2010
540
NO-releasing esters show carbonic anhydrase inhibitory action against human isoforms I and II. 61
20430631 2010
541
American Chemical Society-239th national meeting--Investigating new therapeutic candidates: part 2. 21-25 March 2010, San Francisco, CA, USA. 61
20432181 2010
542
Female pattern hair loss in complete androgen insensitivity syndrome. 61
20128792 2010
543
Changes in trend of newly prescribed anti-glaucoma medications in recent nine years in a Japanese local community. 61
20556196 2010
544
Constraints on the formation age of cometary material from the NASA Stardust mission. 61
20185683 2010
545
[Simultaneous correction for blood matrix effect on determination of magnesium, copper and lead concentration in blood samples by ICP-MS using CAIS]. 61
20384158 2010
546
Disorders of sexual differentiation: surgical challenges of vaginal reconstruction in complete androgen insensitivity syndrome (CAIS). 61
20336898 2010
547
Torsion of the testicle in a patient with complete androgen insensitivity syndrome. 61
20701524 2010
548
A girl with tomboy behavior: lesson from misdiagnosis in a baby with ambiguous genitalia. 61
20051677 2010
549
The Feasibility, Appropriateness, Meaningfulness and Effectiveness of Canine-Assisted Interventions (CAIs) on the Health and Social Care of the Elderly Residing in Long-Term Care: A Comprehensive Systematic Review. 61
27820569 2010
550
238U/235U variations in meteorites: extant 247Cm and implications for Pb-Pb dating. 61
20044543 2010
551
Carbonic anhydrase inhibitors developed through 'click tailing'. 61
20819066 2010
552
Deciphering the mechanism of carbonic anhydrase inhibition with coumarins and thiocoumarins. 61
19911821 2010
553
Drug design studies of the novel antitumor targets carbonic anhydrase IX and XII. 61
20166929 2010
554
Concerns regarding gender change to male in a 46,XY child with complete androgen insensitivity syndrome: comment on Kulshreshtha et al. (2009). 61
19705270 2009
555
Apparent male gender identity in a patient with complete androgen insensitivity syndrome. 61
19636694 2009
556
Complete androgen insensitivity syndrome: diagnosis and management. 61
30780790 2009
557
Fingers as a marker of prenatal androgen exposure. 61
19819951 2009
558
In vivo evaluation of autologous cartilage fragment-loaded scaffolds implanted into equine articular defects and compared with autologous chondrocyte implantation. 61
19934439 2009
559
Carbonic anhydrase inhibitors. Comparison of aliphatic sulfamate/bis-sulfamate adducts with isozymes II and IX as a platform for designing tight-binding, more isoform-selective inhibitors. 61
19731956 2009
560
Carbonic anhydrase-encoded dynamic constitutional libraries: toward the discovery of isozyme-specific inhibitors. 61
19580287 2009
561
Estrogen-specific action on bone geometry and volumetric bone density: longitudinal observations in an adult with complete androgen insensitivity. 61
19376280 2009
562
A cognitive behavioural model and therapy for utero-vaginal agenesis (Mayer-Rokitansky-Küster-Hauser syndrome: MRKH). 61
19508745 2009
563
Apolipoprotein D (APOD) is a putative biomarker of androgen receptor function in androgen insensitivity syndrome. 61
19330472 2009
564
[Case of complete androgen insensitivity syndrome]. 61
19507547 2009
565
Therapeutic applications of glycosidic carbonic anhydrase inhibitors. 61
19058143 2009
566
Case of sisters with complete androgen insensitivity syndrome and discordant Müllerian remnants. 61
18930210 2009
567
Treatment of adult-onset acute macular retinoschisis in enhanced s-cone syndrome with oral acetazolamide. 61
18835469 2009
568
Body composition and metabolic profile in women with complete androgen insensitivity syndrome. 61
19752598 2009
569
Clinical findings in prepubertal girls with inguinal hernia with special reference to the diagnosis of androgen insensitivity syndrome. 61
18752152 2009
570
Toxic Epidermal Necrolysis Induced by the Topical Carbonic Anhydrase Inhibitors Brinzolamide and Dorzolamide. 61
27303208 2008
571
Complete androgen insensitivity syndrome--a review. 61
19064222 2008
572
Sex-reversed phenotype in association with two novel mutations c.2494delA and c.T3004C in the ligand-binding domain of the androgen receptor gene. 61
18342859 2008
573
Intersex patients in military service. 61
19055190 2008
574
[Replacement of androgen receptor gene causes complete androgen insensitivity in a large family]. 61
19087565 2008
575
Comment on "ancient asteroids enriched in refractory inclusions". 61
19008430 2008
576
Prostate screening in patients with 46,XY disorders of sex development--is it necessary? 61
18710761 2008
577
Long-term followup and comparison between genotype and phenotype in 29 cases of complete androgen insensitivity syndrome. 61
18710728 2008
578
Gender assignment and hormonal treatment for disorders of sexual differentiation. 61
18704450 2008
579
Comparison of bone mineral density and body proportions between women with complete androgen insensitivity syndrome and women with gonadal dysgenesis. 61
18463105 2008
580
Extracellular loop C of NPC1L1 is important for binding to ezetimibe. 61
18682566 2008
581
Genetic investigation of the patrilineal kinship structure of early medieval Ireland. 61
18350585 2008
582
Novel mutation in the ligand-binding domain of the androgen receptor gene (l790p) associated with complete androgen insensitivity syndrome. 61
18097502 2008
583
Complete Androgen Insensitivity Syndrome. 61
18760072 2008
584
[Complete androgen insensitivity syndrome: a novel mutation in a Tunisian family]. 61
18462702 2008
585
[Complete androgen insensitivity syndrome: diagnosis and clinical characteristics]. 61
18695842 2008
586
Costs and persistence of alpha-2 adrenergic agonists versus carbonic anhydrase inhibitors, both associated with prostaglandin analogues, for glaucoma as recorded by The United Kingdom General Practitioner Research Database. 61
19668723 2008
587
A novel mutation c.118delA in exon 1 of the androgen receptor gene resulting in complete androgen insensitivity syndrome within a large family. 61
17714709 2008
588
The role of androgen receptors in the masculinization of brain and behavior: what we've learned from the testicular feminization mutation. 54
18374335 2008
589
The chronic ankle instability scale: clinimetric properties of a multidimensional, patient-assessed instrument. 61
19083705 2008
590
Ancient asteroids enriched in refractory inclusions. 61
18356491 2008
591
Familial complete androgen insensitivity syndrome (Morris syndrome or testicular feminization syndrome) in 2 sisters. 61
18418092 2008
592
Laparoscopy and intersex: report of 5 cases of male pseudohermaphroditism. 61
18319558 2008
593
Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. 61
18167490 2008
594
Prevalence of asthma among youth on Hispanic-operated farms in the United States-2000. 61
19064420 2008
595
Fluorescence- and spin-labeled carbonic anhydrase inhibitors. 61
18336316 2008
596
The development of topically acting carbonic anhydrase inhibitors as antiglaucoma agents. 61
18336310 2008
597
Long-term outcome of disorders of sex development. 61
18987501 2008
598
Glaucoma: a review of adjunctive therapy and new management strategies. 61
18035966 2007
599
Design, synthesis, and docking studies of new 1,3,4-thiadiazole-2-thione derivatives with carbonic anhydrase inhibitory activity. 61
17822907 2007
600
Androgen receptor genotyping in a large Australasian cohort with androgen insensitivity syndrome; identification of four novel mutations. 61
17937062 2007
601
Normalization of the vagina by dilator treatment alone in Complete Androgen Insensitivity Syndrome and Mayer-Rokitansky-Kuster-Hauser Syndrome. 61
17449508 2007
602
Androgen insensitivity syndrome: a case report. 61
18330332 2007
603
Conjunctival mucin deficiency in complete androgen insensitivity syndrome (CAIS). 61
17120009 2007
604
Complete androgen insensitivity without Wolffian duct development: the AR-A form of the androgen receptor is not sufficient for male genital development. 61
17408421 2007
605
Prevalence of hospital infection and antibiotic use at a university medical center in Hong Kong. 61
17275959 2007
606
Safety considerations with gastrointestinally active lipid-lowering drugs. 61
17368279 2007
607
Height and bone mineral density in androgen insensitivity syndrome with mutations in the androgen receptor gene. 61
17077943 2007
608
Potential for airborne contamination in turbulent- and unidirectional-airflow compounding aseptic isolators. 61
17353571 2007
609
Carbonic anhydrase inhibitors: inhibition of cytosolic/tumor-associated isoforms I, II, and IX with iminodiacetic carboxylates/hydroxamates also incorporating benzenesulfonamide moieties. 61
17251018 2007
610
Evidence of existence of infectious hypodermal and hematopoietic necrosis virus in penaeid shrimp cultured in China. 61
17118584 2007
611
[CAIS correction for blood matrix effect on determination of lead concentration and isotope ratio by ICP-MS]. 61
17514980 2007
612
Carbonic anhydrase inhibitors as anticonvulsant agents. 61
17504130 2007
613
The development of topically acting carbonic anhydrase inhibitors as anti-glaucoma agents. 61
17504129 2007
614
Regulation of Wolffian duct development. 61
17077643 2007
615
A novel mutation of androgen receptor gene in complete androgen insensitivity syndrome. 61
24790346 2007
616
Helper function of the Wolffian ducts and role of androgens in the development of the vagina. 61
18391520 2007
617
Cervical spine fracture patterns mandating screening to rule out blunt cerebrovascular injury. 61
17188170 2007
618
Fertilizing capacity of boar semen frozen in an extender supplemented with ostrich egg yolk lipoprotein fractions--a pilot study. 61
17937184 2007
619
A naturally occurring mutation in the human androgen receptor of a subject with complete androgen insensitivity confers binding and transactivation by estradiol. 61
17011702 2007
620
Interpersonal traits in childhood: development of the child and adolescent interpersonal survey. 61
17134339 2006
621
Nonfatal injuries to household youth on racial minority-operated farms in the U.S., 2000. 61
17131951 2006
622
Complete androgen insensitivity syndrome in a black South African family: a clinical and molecular investigation. 61
17229664 2006
623
Complete androgen insensitivity syndrome in an X Y female. 61
16899193 2006
624
[Psychosexual aspects of intersex syndromes]. 61
16835789 2006
625
Optic nerve pH and PO2: the effects of carbonic anhydrase inhibition, and metabolic and respiratory acidosis. 61
16879567 2006
626
New zinc binding motifs in the design of selective carbonic anhydrase inhibitors. 61
16918498 2006
627
Nosocomial and community-acquired meticillin-resistant Staphylococcus aureus infections in hospitalized patients (Spain, 1993-2003). 61
16781015 2006
628
X-ray crystallographic studies reveal that the incorporation of spacer groups in carbonic anhydrase inhibitors causes alternate binding modes. 61
16820676 2006
629
Hospital- and community-acquired infections: a point prevalence and risk factors survey in a tertiary care center in Saudi Arabia. 61
16678467 2006
630
R831X mutation of the androgen receptor gene in an adolescent with complete androgen insensitivity syndrome and bilateral testicular hamartomata. 61
16950754 2006
631
A mutation c.C2812T in the androgen receptor gene resulting in Pro817Leu substitution may affect dimerization of the androgen receptor and result in androgen insensitivity syndrome. 61
16759930 2006
632
An uncommon large deletion in the androgen-receptor gene in a XY female with complete androgen insensitivity syndrome. 61
16794370 2006
633
[Clinical management of an androgen insensitivity syndrome]. 61
16673251 2006
634
Five novel androgen receptor gene mutations associated with complete androgen insensitivity syndrome. 61
16470553 2006
635
Complete androgen insensitivity syndrome: report of a case with solitary pelvic kidney. 61
16604972 2006
636
Impaired helix 12 dynamics due to proline 892 substitutions in the androgen receptor are associated with complete androgen insensitivity. 61
16449235 2006
637
[Trends in the prevalence of hospital-acquired infections and hospital use of antibiotics in the Aarhus county]. 61
16545219 2006
638
Proliferation (MIB-1 expression) in oligodendrogliomas: assessment of quantitative methods and prognostic significance. 61
16540741 2006
639
[Androgen insensitivity syndrome in adolescents]. 61
16575123 2006
640
Puberty in subjects with complete androgen insensitivity syndrome. 61
16491011 2006
641
An environmental signature for 323 microbial genomes based on codon adaptation indices. 61
17156429 2006
642
A graphical user interface for a comparative anatomy information system: design, implementation and usage scenarios. 61
17238446 2006
643
[Study of bone mineral density in complete androgen insensitivity syndrome patients]. 61
16412322 2005
644
[Feminizing testicular syndrome with multiple hamartomas and bilateral paratesticular leiomyomas]. 61
16236398 2005
645
Reflections on the diseases linked to mutations of the androgen receptor. 61
16388114 2005
646
Iatrogenic carotid artery injury in neurosurgery. 61
16091974 2005
647
Treatment dilemmas after gonadectomy in complete androgen insensitivity syndrome. 61
16263555 2005
648
Gender identity and recalled gender related childhood play-behaviour in adult individuals with different forms of intersexuality. 61
16176051 2005
649
Mutations in the amino-terminal domain of the human androgen receptor may be associated with partial androgen insensitivity and impaired transactivation in vitro. 61
16151980 2005
650
Gender dysphoria and gender change in androgen insensitivity or micropenis. 61
16010464 2005
651
Inguinal hernia in female infants: a cue to check the sex chromosomes? 61
16042738 2005
652
Complete androgen insensitivity syndrome with persistent Mullerian derivatives: a case report. 61
16091340 2005
653
Carotid artery stents for blunt cerebrovascular injury: risks exceed benefits. 61
15897444 2005
654
CO self-shielding as the origin of oxygen isotope anomalies in the early solar nebula. 61
15902251 2005
655
Topical dorzolamide increases pericentral visual function in age-related maculopathy: pilot study findings with short-wavelength automated perimetry. 61
15799725 2005
656
Chronology of the early Solar System from chondrule-bearing calcium-aluminium-rich inclusions. 61
15846340 2005
657
Supra-canonical 26Al/27Al and the residence time of CAIs in the solar protoplanetary disk. 61
15746387 2005
658
Leydig cell tumor in an elderly patient with complete androgen insensitivity syndrome. 61
15721441 2005
659
Complete androgen insensitivity syndrome: the role of the endocrine surgeon. 61
15869141 2005
660
[Androgen insensitivity syndrome: clinical, hormonal and molecular analysis of 33 cases]. 61
16544039 2005
661
Carbonic anhydrase inhibition increases retinal oxygen tension and dilates retinal vessels. 61
15742212 2005
662
The role of the androgen receptor in CNS masculinization. 54
15713272 2005
663
Household youth on minority operated farms in the United States, 2000: exposures to and injuries from work, horses, ATVs and tractors. 61
15882873 2005
664
Central acetylcholinesterase inhibitors in the treatment of chronic traumatic brain injury-clinical experience in 111 patients. 61
15610946 2005
665
Injuries to youth living on U.S. farms in 2001 with comparison to 1998. 61
16702120 2005
666
[Complete androgen insensitivity syndrome in 16-year-old girl with female phenotype]. 61
15850539 2005
667
Androgen insensitivity syndrome: somatic mosaicism of the androgen receptor in seven families and consequences for sex assignment and genetic counseling. 61
15522944 2005
668
Management of glaucoma: focus on pharmacological therapy. 61
15663346 2005
669
The incidence of complete androgen insensitivity in girls with inguinal hernias and assessment of screening by vaginal length measurement. 61
15868573 2005
670
Novel and recurrent mutations in patients with androgen insensitivity syndromes. 61
15925895 2005
671
Residual activity of mutant androgen receptors explains wolffian duct development in the complete androgen insensitivity syndrome. 61
15531547 2004
672
Mass-independent isotope effect in the earliest processed solids in the solar system: a possible chemical mechanism. 61
15511139 2004
673
Carbonic anhydrase inhibitors: inhibition of human cytosolic isozyme II and mitochondrial isozyme V with a series of benzene sulfonamide derivatives. 61
15482952 2004
674
A novel c.C2754 > T transition in the androgen receptor gene introduces the premature termination codon Q798X and results in a truncated form of the receptor. 61
15724799 2004
675
[Carboxyamido-triazole inhibits substeps of choroidal neovascularization on retinal pigment epithelial cells and choroidal endothelial cells in vitro]. 61
15185118 2004
676
Mg isotope evidence for contemporaneous formation of chondrules and refractory inclusions. 61
15372023 2004
677
Beta-lactam cholesterol absorption inhibitors. 61
15279572 2004
678
Graham Little-Piccardi-Lassueur syndrome associated with androgen insensitivity syndrome (testicular feminization). 61
15196163 2004
679
Carbonic anhydrases: current state of the art, therapeutic applications and future prospects. 61
15499993 2004
680
Inhibition of alpha(1E) Ca(2+) channels by carbonic anhydrase inhibitors. 61
15215649 2004
681
Benzolamide is not a membrane-impermeant carbonic anhydrase inhibitor. 61
15499999 2004
682
Anticoagulation is the gold standard therapy for blunt carotid injuries to reduce stroke rate. 61
15136355 2004
683
Carbonic anhydrase inhibitors: inhibition of the tumor-associated isozyme IX with fluorine-containing sulfonamides. The first subnanomolar CA IX inhibitor discovered. 61
15081039 2004
684
Carbonic anhydrase inhibitors: synthesis and topical intraocular pressure lowering effects of fluorine-containing inhibitors devoid of enhanced reactivity. 61
15139757 2004
685
Identification of a mutant allele of the androgen receptor gene in a family with androgen insensitivity syndrome: detection of carriers and prenatal diagnosis. 61
12898143 2004
686
Concordance of phenotypic expression and gender identity in a large kindred with a mutation in the androgen receptor. 61
14756668 2004
687
Impairment in childhood anxiety disorders: preliminary examination of the child anxiety impact scale-parent version. 61
15142397 2004
688
Distributional map of the terminal and sub-terminal sugar residues of the glycoconjugates in the prepubertal and postpubertal testis of a subject affected by complete androgen insensitivity syndrome (Morris's syndrome): lectin histochemical study. 61
14702164 2004
689
Designing of Novel Carbonic Anhydrase Inhibitors and Activators. 61
15320807 2004
690
Designing of novel carbonic anhydrase inhibitors and activators. 61
15328829 2004
691
Farm fatalities to youth 1995-2000: A comparison by age groups. 61
15178233 2004
692
On-farm falls among youth less than 20 years old in the U.S. 61
15017803 2004
693
Identification of a mutant allele of the androgen receptor gene in a family with androgen insensitivity syndrome: detection of carriers and prenatal diagnosis. 61
14605819 2003
694
Role of estrogen and androgen in pubertal skeletal physiology. 61
12868122 2003
695
Is complete androgen insensitivity syndrome associated with alterations in the meibomian gland and ocular surface? 61
12883343 2003
696
Sexual function in women with complete androgen insensitivity syndrome. 61
12849818 2003
697
Complete androgen insensitivity syndrome due to X chromosome inversion: a clinical report. 61
12838569 2003
698
Optimal scan time for evaluating pancreatic disease with positron emission tomography using F-18-fluorodeoxyglucose. 61
12971645 2003
699
Clinical, hormonal, behavioral, and genetic characteristics of androgen insensitivity syndrome in a Brazilian cohort: five novel mutations in the androgen receptor gene. 61
12843171 2003
700
Bilateral orchiectomy for the surgical treatment of complete androgen insensitivity syndrome: patient outcome after 1 year of follow-up. 61
12855103 2003
701
Androgen receptor functions from reverse genetic models. 54
12943692 2003
702
Re "Persistence of Müllerian remnants in complete androgen insensitivity syndrome". 61
12880133 2003
703
Contemporaneous formation of chondrules and refractory inclusions in the early Solar System. 61
12802328 2003
704
Spinal carbonic anhydrase contributes to nociceptive reflex enhancement by midazolam, pentobarbital, and propofol. 61
12657854 2003
705
Switching from systemic to the topical carbonic anhydrase inhibitor dorzolamide: effect on the quality of life of glaucoma patients with drug-related side effects. 61
14509130 2003
706
Psychological outcomes and gender-related development in complete androgen insensitivity syndrome. 61
12710824 2003
707
Carbonic anhydrase inhibitors: inhibition of cytosolic isozymes I and II with sulfamide derivatives. 61
12617903 2003
708
Genital skin fibroblasts (GF) of patients with androgen insensitivity syndrome express higher insulin-like growth factor binding protein (IGFBP)-2, -3 and -5 than GF of normally virilized males. 61
12876417 2003
709
Exclusion of androgen insensitivity syndrome in girls with inguinal hernias: current surgical practice. 61
12598968 2002
710
Complete androgen insensitivity syndrome: effect on human meibomian gland secretions. 61
12470144 2002
711
Persistence of Müllerian remnants in complete androgen insensitivity syndrome. 61
12503865 2002
712
Acetazolamide: future perspective in topical glaucoma therapeutics. 61
12429455 2002
713
Abolition of hypertension-induced end-organ damage by androgen receptor blockade in transgenic rats harboring the mouse ren-2 gene. 54
12397037 2002
714
Lead isotopic ages of chondrules and calcium-aluminum-rich inclusions. 61
12215641 2002
715
46,XY intersex individuals: phenotypic and etiologic classification, knowledge of condition, and satisfaction with knowledge in adulthood. 61
12205282 2002
716
Long-term perspectives for 46,XY patients affected by complete androgen insensitivity syndrome or congenital micropenis. 61
12428209 2002
717
Disorders of androgen action. 61
12428202 2002
718
Androgen deficiency, Meibomian gland dysfunction, and evaporative dry eye. 61
12114274 2002
719
[Deletion of thymine at position 2298 in exon 5 of the androgenic receptor gene causing complete androgen insensitivity syndrome]. 61
11927080 2002
720
Androgen receptor mutations causing human androgen insensitivity syndromes show a key role of residue M807 in Helix 8-Helix 10 interactions and in receptor ligand-binding domain stability. 61
11818512 2002
721
Existence of an 16O-rich gaseous reservoir in the solar nebula. 61
11834830 2002
722
Synthesis of fluorescent biochemical tools related to the 2-azetidinone class of cholesterol absorption inhibitors. 61
11814786 2002
723
Transition C2718T in the AR gene, resulting in generation of a termination codon and truncated form of the androgen receptor, causes complete androgen insensitivity syndrome. 61
12084976 2002
724
Characterization of a novel receptor mutation A-->T at exon 4 in complete androgen insensitivity syndrome and a carrier sibling via bidirectional polymorphism sequence analysis. 61
11744994 2002
725
Postnatal changes of T, LH, and FSH in 46,XY infants with mutations in the AR gene. 61
11788616 2002
726
A 19 year old with complete androgen insensitivity syndrome and juvenile fibroadenoma of the breast. 61
11843857 2001
727
Decreased expression of IGF-II and its binding protein, IGF-binding protein-2, in genital skin fibroblasts of patients with complete androgen insensitivity syndrome compared with normally virilized males. 61
11600534 2001
728
Blunt cerebrovascular injuries: diagnosis and treatment. 61
11493785 2001
729
Molecular basis of androgen insensitivity. 61
11420135 2001
730
Novel amino acid substitutional mutation, tyrosine-739-aspartic acid, in the androgen receptor gene in complete androgen insensitivity syndrome. 61
11380707 2001
731
Sex, infertility and the molecular biology of the androgen receptor. 61
11396657 2001
732
The effects of oestrogens on linear bone growth. 61
11392377 2001
733
Androgen receptor gene mutation associated with complete androgen insensitivity syndrome and Sertoli cell adenoma. 61
11293168 2001
734
Novel molecular defects in the androgen receptor gene of Mexican patients with androgen insensitivity. 61
11260228 2001
735
[An acceptor-splice-site mutation responsible for complete androgen insensitivity syndrome]. 61
11172634 2001
736
46, XY female--a case report. 61
11242631 2001
737
Cerebral-abdominal interganglionic coordinating neurons in Aplysia. 61
11152718 2001
738
The testosterone:androstenedione ratio in male undermasculinization. 61
11155091 2000
739
Methazolamide 1% in cyclodextrin solution lowers IOP in human ocular hypertension. 61
11006251 2000
740
Bilateral testicular tumors in androgen insensitivity syndrome. 61
11144509 2000
741
Inhibin-alpha CD99, HEA125, PLAP, and chromogranin immunoreactivity in testicular neoplasms and the androgen insensitivity syndrome. 61
11014571 2000
742
Complete androgen insensitivity syndrome: long-term medical, surgical, and psychosexual outcome. 61
10946863 2000
743
Calcium-aluminum-rich inclusions from enstatite chondrites: indigenous or foreign? 61
10958775 2000
744
Hamartoma in a pubertal patient with complete androgen insensitivity syndrome and R(831)X mutation of the androgen receptor gene. 61
10899520 2000
745
Pharmacological therapy for glaucoma: a review. 61
10776828 2000
746
Phenotypic features, androgen receptor binding, and mutational analysis in 278 clinical cases reported as androgen insensitivity syndrome. 61
10690872 2000
747
[Sexual differentiation of the human brain]. 61
10907369 2000
748
Molecular analysis of familial androgen insensitivity syndrome due to replacement of glutamic acid 802 by lysine. 61
11185742 2000
749
Preclinical overview of brinzolamide. 61
10665514 2000
750
A substitutional mutation in the DNA binding domain of the androgen receptor causes complete androgen insensitivity syndrome. 61
10599549 1999
751
Bilateral Müllerian duct remnants. A scanning electron microscope study in a case of complete androgen insensitivity syndrome. 61
15512392 1999
752
Complete androgen insensitivity in a 47,XXY patient with uniparental disomy for the X chromosome. 61
10449642 1999
753
Complete androgen insensitivity caused by a new frameshift deletion of two base pairs in exon 1 of the human androgen receptor gene. 61
10323411 1999
754
Androgen receptor gene mutations in 46,XY females with germ cell tumours. 61
10221692 1999
755
16O excesses in olivine inclusions in Yamato-86009 and Murchison chondrites and their relation to CAIs. 61
9933162 1999
756
Analysis of exon 1 mutations in the androgen receptor gene. 61
10571951 1999
757
[Diagnosis and management of patients with sex differentiation disorders: experience at the Unit of Medical Genetics of the University of Zulia, Maracaibo, Venezuela]. 61
9927802 1998
758
Oxygen isotope exchange between refractory inclusion in Allende and solar nebula gas. 61
9874638 1998
759
Oxygen isotope exchange between refractory inclusion in allende and solar nebula Gas 61
9836634 1998
760
Evaluation of neutralized chemical agent identification sets (CAIS) for skin injury with an overview of the vesicant potential of agent degradation products. 61
9840748 1998
761
Oxygen reservoirs in the early solar nebula inferred from an allende CAI 61
9774267 1998
762
Oxygen reservoirs in the early solar nebula inferred from an Allende CAI. 61
9841405 1998
763
Changes in bone mineral density after orchidectomy and hormone replacement therapy in individuals with androgen insensitivity syndrome. 61
9804237 1998
764
Acute inhalation toxicity of neutralized chemical agent identification sets (CAIS) containing agent in chloroform. 61
9804437 1998
765
Oxygen isotopic abundances in calcium- aluminum-rich inclusions from ordinary chondrites: implications for nebular heterogeneity. 61
9545215 1998
766
Expression of androgen receptor mRNA during mouse embryogenesis. 54
9533962 1998
767
Glaucoma medications, glaucoma therapy, and the evolving paradigm. 61
9549260 1998
768
Shortage of glutamine (CAG) homopolymeric repeats suppresses the expression of the androgen receptor in familial cases with complete androgen insensitivity syndrome. 61
9526703 1998
769
A new missense substitution at a mutational hot spot of the androgen receptor in siblings with complete androgen insensitivity syndrome. 61
9554754 1998
770
Molecular analysis of the androgen receptor gene in 4 patients with complete androgen insensitivity. 61
9544375 1998
771
Altered bone mineral density in patients with complete androgen insensitivity syndrome. 61
9973670 1998
772
[Measurements of the gravity of injuries in patients with head injuries by the AIS/90 manual and the CAIS/85 chart]. 61
9592551 1998
773
Estrogen secretion from a malignant sex cord stromal tumor in a patient with complete androgen insensitivity. 61
9423767 1997
774
[Active electronic hearing implants for middle and inner ear hearing loss--a new era in ear surgery. II: Current state of developments]. 61
9445848 1997
775
Pituitary apoplexy developed in a patient with androgen insensitivity syndrome. 61
9364255 1997
776
Complete androgen insensitivity syndrome. Molecular characterization in two Chinese women. 61
9252933 1997
777
Assessment of androgen receptor function in genital skin fibroblasts using a recombinant adenovirus to deliver an androgen-responsive reporter gene. 54
9177411 1997
778
DNA analysis of the androgen receptor gene in two cases with complete androgen insensitivity syndrome. 61
9255042 1997
779
Wide variation in androgen receptor dysfunction in complete androgen insensitivity syndrome. 61
9328206 1997
780
Androgen insensitivity with mental retardation: a contiguous gene syndrome? 61
9039995 1997
781
Complete androgen insensitivity syndrome: clinical and anatomopathological findings in 23 patients. 61
9101272 1997
782
Clinical and biochemical investigations and molecular analysis of subjects with mutations in the androgen receptor gene. 61
9039340 1996
783
Successful diagnosis and surgical laparoscopic treatment of a woman with complete androgen insensitivity syndrome. 61
9132308 1996
784
Rapid detection of a mutation hot-spot in the human androgen receptor. 61
9001799 1996
785
Evidence for Widespread 26Al in the Solar Nebula and Constraints for Nebula Time Scales 61
8670407 1996
786
G protein gamma subunits with altered prenylation sequences are properly modified when expressed in Sf9 cells. 61
8702508 1996
787
Membrane carbonic anhydrase (IV) and ciliary epithelium. Carbonic anhydrase activity is present in the basolateral membranes of the non-pigmented ciliary epithelium of rabbit eyes. 61
8795459 1996
788
A clinician looks at androgen resistance. 61
8733002 1996
789
Corpus albicans-like structures in the gonads in androgen insensitivity syndrome. 61
8786209 1996
790
Molecular basis of androgen insensitivity. 61
8732995 1996
791
Molecular modeling and in vitro investigations of the human androgen receptor DNA-binding domain: application for the study of two mutations. 61
8647313 1996
792
Laparoscopic gonadectomy in a woman with complete androgen insensitivity syndrome. 61
9050649 1996
793
Premature termination mutation (772Glu-->stop) in the hormone-binding domain of the androgen receptor in a patient with the receptor-negative form of complete androgen insensitivity syndrome. 61
8574287 1995
794
Bone mass in androgen-insensitivity syndrome: response to hormonal replacement therapy. 61
7584881 1995
795
Genetic counselling in complete androgen insensitivity syndrome: trinucleotide repeat polymorphisms, single-strand conformation polymorphism and direct detection of two novel mutations in the androgen receptor gene. 61
7641413 1995
796
Androgen receptor mutations. 61
7626493 1995
797
Complete androgen insensitivity syndrome due to a new frameshift deletion in exon 4 of the androgen receptor gene: functional analysis of the mutant receptor. 61
7649349 1995
798
Characterization of alternative amino acid substitutions at arginine 830 of the androgen receptor that cause complete androgen insensitivity in three families. 61
7633398 1995
799
An unusual presentation of complete androgen insensitivity syndrome in general practice. 61
7715876 1995
800
Androgen action. 54
8845582 1995
801
Evaluation of the tubuloglomerular feedback system in human subjects. 61
7712144 1995
802
Binding of sex steroid binding protein to plasma membranes of human testis. 54
7826895 1994
803
Laparoscopic gonadectomy in complete androgen insensitivity syndrome. 61
9050539 1994
804
Anti-müllerian hormone in children with androgen insensitivity. 61
7962305 1994
805
[Testicular feminization. The androgen insensitivity syndrome. A case report]. 61
7959153 1994
806
Complete androgen insensitivity due to a splice-site mutation in the androgen receptor gene and genetic screening with single-stranded conformation polymorphism. 61
8174721 1994
807
Gonadotropin regulation during puberty in complete androgen insensitivity syndrome with testicles in situ. 61
7698719 1994
808
A new mutation within the deoxyribonucleic acid-binding domain of the androgen receptor gene in a family with complete androgen insensitivity syndrome. 61
8224266 1993
809
Renal papillary cytoplasmic granularity and potassium depletion induced by carbonic anhydrase inhibitors in rats. 61
8115822 1993
810
An exonic point mutation creates a MaeIII site in the androgen receptor gene of a family with complete androgen insensitivity syndrome. 61
8103398 1993
811
Single nucleotide substitution of the androgen receptor gene in a case with receptor-positive androgen insensitivity syndrome (complete form). 61
8498155 1993
812
Secondary processing of chondrules and refractory inclusions (CAIs) by gasdynamic heating. 61
11540090 1993
813
Prenatal prediction of androgen insensitivity syndrome using exon 1 polymorphism of the androgen receptor gene. 61
1472458 1992
814
A unique point mutation in the androgen receptor gene in a family with complete androgen insensitivity syndrome. 61
1426313 1992
815
Point mutations detected in the androgen receptor gene of three men with partial androgen insensitivity syndrome. 61
1424203 1992
816
[A laboratory test for the detection of androgen resistance using sex hormone-binding globulin]. 54
1481386 1992
817
Müllerian remnants in complete androgen insensitivity syndrome. 61
1358839 1992
818
Intestinal vaginoplasty for congenital absence of the vagina. 61
1640339 1992
819
Incomplete testicular feminization syndrome: studies of 17 beta-oestradiol-binding activity and aromatase activity in cultured genital fibroblasts showing impaired dihydrotestosterone-binding. 54
1626917 1992
820
Urothelial hyperplasia induced by carbonic anhydrase inhibitors (CAIs) in animals and its relationship to urinary Na and pH. 61
1601202 1992
821
Molecular analysis of the androgen receptor gene in 52 patients with complete or partial androgen insensitivity syndrome: a collaborative study. 61
1356901 1992
822
Androgen dependent stimulation of aromatase activity in genital skin fibroblasts from normals and patients with androgen insensitivity. 61
1769135 1991
823
Evidence for a partial deletion in the androgen receptor gene in a phenotypic male with azoospermia. 61
1750490 1991
824
Calcic micas in the allende meteorite: evidence for hydration reactions in the early solar nebula. 61
17843228 1991
825
Probing genomic deoxyribonucleic acid for gene rearrangement in 14 patients with androgen insensitivity syndrome. 61
2001749 1991
826
The effect of cyclooxygenase inhibition on the ocular hypotensive action of topical carbonic anhydrase inhibitors in rabbits. 61
1783853 1991
827
Comparative tolerability of topical carbonic anhydrase inhibitor MK-927 and its S-enantiomer MK-417. 61
2044968 1991
828
Functional characterization of naturally occurring mutant androgen receptors from subjects with complete androgen insensitivity. 61
2082179 1990
829
Aromatase activity in genital skin fibroblasts from normal and androgen-insensitive individuals. 61
2103574 1990
830
Incidence of intratubular germ cell neoplasia in androgen insensitivity syndrome. 61
2173324 1990
831
Processing of refractory meteorite inclusions (CAIs) in parent-body atmospheres. 61
11538400 1990
832
The 56 kDa androgen-binding protein in human genital skin fibroblasts: its relation to the human androgen receptor. 61
2311825 1990
833
[Local carbonic anhydrase inhibitors MK-927 and Mk-417. Effect and tolerance]. 61
2086420 1990
834
Seminoma in pubertal patient with androgen insensitivity syndrome. 61
2782332 1989
835
Clinical prospective injury severity scoring: when is it accurate? 61
2498528 1989
836
Photoaffinity labelling with [3H]R1881 of androgen receptors from human cultured genital fibroblasts of normal individuals and patients with androgen receptor abnormalities. 61
3260306 1988
837
Evidence for secondary 5 alpha-reductase deficiency in genital and supra-pubic skin of subjects with androgen insensitivity syndrome. 61
3164158 1988
838
Embryonal carcinoma in two cases of androgen insensitivity syndrome: clinical, endocrinological and pathological features. 61
3148467 1988
839
The Abbreviated Injury Scale, 1985 revision: a condensed chart for clinical use. 61
3339667 1988
840
The modulating effect of estrogens on luteinizing hormone release in complete androgen insensitivity syndrome before and after gonadectomy and cyclic steroid application. 61
2444447 1987
841
Failure of the müllerian regression factor in two patients with complete androgen insensitivity syndrome. 61
3118446 1987
842
Androgen insensitivity in forty-nine patients: classification based on clinical and androgen receptor phenotypes. 61
3447937 1987
843
Complete androgen insensitivity syndrome characterized by increased concentration of a normal androgen receptor in genital skin fibroblasts. 61
3088020 1986
844
Aromatase activity in human skin fibroblasts: characterization by an enzymatic method. 61
3747512 1986
845
Neurochemical and behavioral effects of catecholamine and protein synthesis inhibitors in mice. 61
3703899 1986
846
Androgen binding in nuclear matrix of human genital skin fibroblasts from patients with androgen insensitivity syndrome. 61
3944238 1986
847
The presence of Müllerian remnants in the complete androgen insensitivity syndrome: a steroid hormone-mediated defect? 61
3753943 1986
848
Incomplete androgen insensitivity: asymmetry in morphology and steroid profile and metabolism of the gonads. An analysis of a case. 61
4090916 1985
849
Specific 5 alpha-dihydrotestosterone receptor and 5 alpha-reductase activity in human amniotic fluid cells. 61
6507533 1984
850
Carbonic anhydrase inhibitors induce elevations in human whole-blood zinc levels. 61
6334510 1984
851
Loss of Ca2+-dependent regulation in glycerinated skeletal muscle contraction. 61
6358584 1983
852
Androgen receptors in cultured human skin fibroblasts. 61
7138781 1982
853
Human complete androgen insensitivity with normal dihydrotestosterone receptor binding capacity in cultured genital skin fibroblasts: evidence for a qualitative abnormality of the receptor. 61
7076808 1982
854
[Voluminous gonadal cysts in a case of complete "androgen insensitivity syndrome". I. Clinical considerations]. 61
7393490 1980
855
[Voluminous gonadal cysts in a case of complete "androgen insensitivity syndrome". II. Endocrinological studies]. 61
7393491 1980
856
Building a standardized alcoholism interview schedule. 61
668491 1978
857
Partial androgen insensitivity: the Reifenstein syndrome revisited. 61
876326 1977
858
Carbonic anhydrase inhibitor side effects. Serum chemical analysis. 61
889513 1977
859
[ACTIVITY OF THE CENTRE FRAN CAIS DES SALMONELLA OF THE INSTITUT PASTEUR (FOURTH REPORT: 1961-63)]. 61
14266711 1964

Variations for Complete Androgen Insensitivity Syndrome

Expression for Complete Androgen Insensitivity Syndrome

Search GEO for disease gene expression data for Complete Androgen Insensitivity Syndrome.

Pathways for Complete Androgen Insensitivity Syndrome

GO Terms for Complete Androgen Insensitivity Syndrome

Cellular components related to Complete Androgen Insensitivity Syndrome according to GeneCards Suite gene sharing:

(showing 3, show less)
# Name GO ID Score Top Affiliating Genes
1 extracellular space GO:0005615 9.7 PTGDS MUC5AC MUC1 IGFBP3 IGFBP2 IGF2
2 extracellular region GO:0005576 9.28 SHBG PTGDS MUC5AC MUC1 IGFBP3 IGFBP2
3 Golgi lumen GO:0005796 9.13 MUC5AC MUC1 CGA

Biological processes related to Complete Androgen Insensitivity Syndrome according to GeneCards Suite gene sharing:

(showing 5, show less)
# Name GO ID Score Top Affiliating Genes
1 positive regulation of MAPK cascade GO:0043410 9.43 IGFBP3 IGF2 AR
2 positive regulation of activated T cell proliferation GO:0042104 9.32 IGFBP2 IGF2
3 positive regulation of insulin-like growth factor receptor signaling pathway GO:0043568 9.16 IGFBP3 AR
4 regulation of insulin-like growth factor receptor signaling pathway GO:0043567 8.96 IGFBP3 IGFBP2
5 prostate gland growth GO:0060736 8.62 CYP19A1 AR

Molecular functions related to Complete Androgen Insensitivity Syndrome according to GeneCards Suite gene sharing:

(showing 4, show less)
# Name GO ID Score Top Affiliating Genes
1 insulin-like growth factor binding GO:0005520 9.26 IGFBP3 IGFBP2
2 insulin-like growth factor I binding GO:0031994 9.16 IGFBP3 IGFBP2
3 insulin-like growth factor II binding GO:0031995 8.96 IGFBP3 IGFBP2
4 androgen binding GO:0005497 8.62 SHBG AR

Sources for Complete Androgen Insensitivity Syndrome

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA